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FOREWORD
This document contains a summary of the conceptual design of the
Skylab M133 Sleep Monitoring Experiment and a comprehensive compilation
of the data-analysis results from the three Skylab missions. Preliminary
research directed toward the automatic monitoring of sleep during space-
flight was begun in the Neurophysiology Laboratories of The Methodist
Hospital and Baylor College of Medicine, Houston, in 1966. This and sub-
sequent contractual support from the National Aeronautics and Space
Administration led eventually to the finalization of flight-hardware design
and to the specific experimental protocol.
Detailed information regarding particular aspects of the M133 system
and its performance during preflight testing procedures is provided in the
progress and final reports submitted to NASA in association with the individual
contracts. In addition, detailed specifications for the flight hardware and
experimental requirements are summarized in the following documents of the
National Aeronautics and Space Administration (Skylab Program, Lyndon B.
Johnson Space Center, Houston, Texas):
1. End Item Specification: Flight Hardware for Sleep Monitoring
.Experiment (Experiment M133), March 3, 1971, and updated
(MSC-02791)
2. Experiment Requirements Document for Sleep Monitoring Experiment
(Experiment M133), March 3, 1971, and updated (MSC-02790)
The results of extensive preflight testing of the M133 system are included
in the report of the Skylab Medical Experiments Altitude Test (SMEAT), published
by the National Aeronautics and Space Administration, Lyndon B. Johnson Space
Center (NASA TMX-58115, 1973).
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ABSTRACT
Astronauts on pre-Skylab missions commonly complained of insomnia,
and in some cases periods of sleep loss degraded crew performance. 	 In-
vestigation of this situation was important in planning future long-term
flights; subsequently, the first objective measurements of man's ability to
obtain adequate sleep during prolonged spaceflight were made during the
three Skylab flights.
EEG (electroencephalographic), EOG (elect ro-oculographic), and head-
R
motion signals were acquired during sleep by use of an elastic recording cap
containing sponge electrodes and an attached miniature preamplifier/accelerom-
eter unit.
	
A control-panel assembly, mounted in the sleep compartment, tested
electrodes, preserved analog signals, and automatically analyzed data in real
time (providing a telemetered indication of sleep stage).
One astronaut was studied per flight, and while there was considerable
't-	 -	 --h,--- individual variation, several characteristics were common to all three:
r (,l)	 Stage 3 sleep increased inflight and decreased in the postflight period.(2)	 Stage 4 was consistently decreased postflight, although this stage was
variable inflight.
	
(3)	 Stage REM (rapid eye movement) was elevated, and
REM latency decreased in the late postflight period (after day R+3). 	 (4)	 The
number of awakenings during sleep_ either showed no change or decreased 'in-
flight.
In only the 28-day mission was there a significant decrease in total sleep
time; in that case it was a result of voluntarily reduced rest time and was not
due to difficulty in sleeping nor frequent awakening. 	 The subject on the 84-day
mission experienced some difficulty in the first half of the flight, showing a
decreased total sleep time and increased sleep latency, but this resolved
itself with time.	 Sleep latency presented no problem in the other flights.
While many of the findings are statistically significant, in no case would they
be expected to produce a noticeable decrement of performance capability.
These findings suggest that men are able to obtain adequate sleep in
regularly scheduled eight-hour rest periods during extended space missions.
It seems likely, based upon these results, that the problems encountered in
earlier spaceflights did not arise from the zero-g environment per se, but
possibly were a result of more restricted living and working areas in the pre-
Skylab spacecraft.
1
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INTRODUCTION
Prior to Skylab, very little objective information had been obtained
oncerning the ability of man to sleep in space. Only by continuous EEG
elect roencephalographic) monitoring can such information be obtained,
.nd the technical problems associated with acquisition and analysis in space
^re significant. Before the advent of manned spaceflight, there was some
concern about the possible adverse effects of this weightless environment
upon sleep characteristics (Berry, 1970). During the Gemini program,
however, it became apparent that fairly long duration spaceflight was not
associated with drastic alterations of sleeping behavior. Astronauts could
sleep in space and, on at least some occasions, did so fairly well. In the
Gemini and Apollo programs, though, it became clear that in many instances
insomnia was a problem. Sleep loss, while not absolute, was sufficient in
some instances to result in performance decrements. In some instances,
sleeping difficulties resulted in the use of hypnotic drugs to promote sleep
and amphetamine-type medication to increase alertness following sleep loss.
t
It has long been recognized that sleep deprivation is associated with
degradation of performance, the amount or severity of the performance
decrement generally increasing in proportion to the length of the sleep
loss (Naitoh, 1969)• Since crew members areexpected to perform at a
high level throughout a mission, their ability to obtain sufficient sleep be-
comes an important variable in terms of overall mission planning_ and
scheduling of daily work-rest periods.
The United States' first attempt to record the electroencephalogram
during spaceflight was carried out durL^g the Gemini VII mission in 1965
(Maulsby, 1966; Maulsby and Kellaway, 1966; Adey et al., 1967; Burch
et al. 1971). Technical difficulties associated with electrode attachment
limited recording to slightly under 55 hours. During that time, two sleep
periods were observed, and while the first was found to be inadequate in
terms of duration and quality, the second was considered to be normal.
Postflight examination of the recorded EEG disclosed no pathological
changes nor definite alterations which could be attributed to the weightless
state. The limited duration of this recording did not permit an adequate
analysis of sleep characteristics during long-term spaceflight, and con-
sequently, the purpose of the sleep monitoring experiment developed for
Skylab was to obtain the first truly objective evaluation of man's ability
to sleep during extended space travel. An historical overview of the devel-
opment of the experiment is illustrated in Fig. 1 in which specific contract,
support to this laboratory is acknowledged.
Each three-man crew carried out a wide variety of work during the
three Skylab missions, accomplishing a number of research projects
2
covering the physical and biomedical sciences. The working volume of the
Skylab orbiting laboratory was over 12 000 ft 3 , and consequently it was
comparable to a moderate-sized house. There was adequate space to provide
separate facilities for work, recreation, meals, and sleep, and the crews
followed a 24-hour schedule based upon Central Standard Time, to which
they were accustomed on the ground. At an altitude of approximately 270
statute miles, Skylab circled the Earth approximately every 93 minutes.
Each astronaut had his own sleeping compartment, which was equipped
with a sleep-restraint system quite similar in appearance and function to a
sleeping bag. An eight-hour rest period was typically scheduled between
10 p. m. and 6 a. m. for all three crew members, although variations in this
protocol were occasionally necessitated by specific work requirements.
Sleep was studied in an objective manner on three of the Skylab astro-
nauts, one each during the 28-, 59-, and 84-day missions.
METHODS
A complete system for analyzing sleep during spaceflight was designed
for this 'experiment and included data-acquisition hardware, onboard-analysis
components, and a capability for real-time telemetry.
Automatic analysis of the electroencephalogram (EEG), electro-oculogram
(EOG), and head-motion signals was accomplished by onboard equipment. The
system's output, consisting of sleep-stage information, was telemetered in
near 'real time to Mission Control, where a profile of sleep stage versus time
was accumulated. The analog signals (EEG, EOG, and head motion) were also
preserved by onboard magnetic-tape recorders, thus allowing a more detailed
postflight analys is.
The flight-hardware components are shown in Fig. 2. When sleep
monitoring was desired, the astronaut wore a recording cap that contained
electrodes for detecting EEG and EOG. Signal amplification was accomplished
by a preamplification unit which attached to the cap near the vertex of the head.
A dual-axis accelerometer, included within the preamplifier housing, provided
information concerning movement of the subject's head. A control-panel
assembly was mounted in the subject's sleep compartment and attached to the
preamplifier by means of a flexible cable. Within the control-panel assembly,
additional circuitry accomplished automatic electrode testing, sleep analysis,
and generation of the telemetry output signal indicative of the subject's current
level of consciousness. _ Analog recording was accomplished by two tape re-
corders attached to the rear portion of the control-panel assembly.
V
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Data Acquisition
Recording Cap
In developing the sleep monitoring system, we directed considerable
effort toward the problems associated with data acquisition. Biomedical
electrodes have always presented problems in spaceflight because they re-
quire excessive time for proper application, are often uncomfortable, and
are prone to dislodgment during the subject's activity. Several years ago,
Kado and Adey (1968) and Hanley et al. (1971) considered the particular
problems posed by long-term EEG monitoring, resulting in the development
of a sponge-type electrode mounted in an elastic cap. This general concept
was extended in evolving the Skylab system, and a new, disposable recording
cap was developed (Frost et al. , 1970; Frost, 1971, 1972, 1973) which con-
tained miniaturized, flexible, sponge electrodes prefilled with an electro-
lyte solution to minimize preparation time.
The recording cap is illustrated in Fig. 3; the picture was taken during
the 59-day mission (Skylab 3). The electrodes, attached inside the elastic
cap, were joined by wires to a miniature connector at the vertex, which
permitted rapid linkage with the preamplifier assembly. The cap contained
seven electrodes; four electrodes (left and right central positions, C l and
C 2, and left and right occipital positions, 0 1 and 0 2) provided a composite
EEG channel (Cl and C2 paired and referenced to 0 1 and 0 2 paired); two
(one lateral to and one above the left eye) provided one EOG channel; and
one served as a ground. Following the sleep period, the preamplifier was
disconnected, and the used cap was discarded; i. e., a new cap was used for
each recording session.
Recording Electrode
The base was flexible silicone rubber, with a silver-silver chloride
disc incorporated in one surface (see Fig. 4A). A conical, silicone-rubber
sponge was attached to the base so that it made contact with the surface of the
disc.
The sponge apex terminated in a cylindrical protrusion (the filling and
sealing tab), and the entire electrode was covered with a thin, flexible., non-
porous coating (Fig. 4B). This coating consisted of three layers of vinyl
plastic and an extremely thin outer layer of Parylene C polymer material
(Union Carbide). During the manufacturing process, an electrically conduc-
tive gel was injected through the electrode's tab into the body of the sponge
until the porous structure became saturated. The _injection needle was then
withdrawn and the tip resealed. The completed electrode was then attached
to the cap, which could be stored indefinitely in a laminated metalized plastic
bag,
`	
4
1r
	
	
To prepare for a recording period, the subject simply removed the
cap from its protective bag, attached the preamplifier unit, and, using a
scissors, snipped the sealing tabs from the seven electrodes. The cap was
then donned, and the exposed portions of the electrodes (see Fig. 4C) made
contact with the scalp. The cap was held in place during a sleep period by
a padded chin strap attached with velcro fasteners.
Preamplifier Assembly
Matched pairs of field-effect transistors provided a gain of approxi-
mately 10 and preamplified EEG and EOG signals within this unit. A dual-
axis accelerometer and its associated preamplifier also were included for
detecting head motion in the lateral (side -to -side) and vertical (up-down)
axes. The amplified signals passed through a four-ft cable (see Fig. 2)
to the control-panel assembly, which provided final amplification.
Circuitry within the preamplifier also provided electroshock protec-
tion for the subject and electrostatic protection for the system's electronic
°- -
	
	
components - Each electrode lead was actively protected against current
flow in excess of 200 i A (peak) .
Control-Panel Assembly
This unit was mounted on the wall of the subject's sleep compartment,
}
	
	
within easy reach of the sleep restraint. Front-panel controls included the
power switch, a mode-selection switch, tape -recorder -selection switch,
and a subject gain-factor potentiometer. The circuitry accomplished
electrode testing, signal amplification, and data analysis, and provided
outputs to the analog-tape recorders and the spacecraft telemetry system.
The electrode-test section of the control-panel assembly performed
automatic testing of each recording electrode before the sleep period began.
The front panel, readily visible to the subject in the sleep compartment
while applying the cap, contained a series of indicator lamps, each represent-
ing one sponge-electrode sensor in the cap. The lamps were arranged in a
configuration simulating the relative position on the head. After the subject
donned the cap, he moved the mode-selection switch from the off to the test
position, thereby activating the test circuitry. A small test current (=10 uA)
passed through the single ground electrode to each of the six recording elec-
trodes in succession, and the amount of current passed by each electrode was
sensed to provide an indication of interelectrode resistance. If a given elec-
trode were in proper scalp contact, its resistance was 50 000 0 or less, and
this cond.'ition was indicated by illumination of the corresponding lamp on the
panel display. Improper contact, indicated by failure of any lamp to illumi-
nate, ust.ally could be resolved by slightly rocking the sensor to position the
electrode tip through the hair and against the scalp.
5	 ,
Inflight Data Analysis
The data-analysis equipment also had been designed to meet the limita-
Lions imposed by spaceflight. To supply sleep-stage information in near real
time while minimizing telemetry time and bandwidth, the EEG, EOG, and
head-motion signals were processed onboard by a small, special-purpose
computational device. Since the unit's output was expressed in terms of
sleep stage (i. e. , restricted to one of seven possible states) and changed
only slowly, the information content could be telemetered adequately by
transmitting only three bits at a rate of 1. 25 samples/sec (as opposed to
approximately 32 bits at a rate of 100 samples/sec, which would be required
to transmit the unprocessed data).
The clinical criteria for evaluating sleep are based upon changes in the
EEG and EOG patterns accompanying the observed behavioral changes during
the transition from the awake condition to one of deep sleep (Rechtschaffen
and Kales, 1968). The awake, or nonsleep, state is characterized electro-
n
encephalographically by alpha activity (8-12 Hz) and/or low-amplitude, mixed-
frequency activity. Stage 1, or very light sleep, is characterized by low-
amplitude EEG signals of a predominantly lower frequency (5-7 Hz) than the
awake state. During stage 2 sleep, the EEG exhibits a somewhat random
frequency, low-amplitude background activity upon which is superimposed
occasional bursts (spindles) of I2-14 Hz activity and/or relatively high voltage
transient forms exceeding 0. 5 sec in duration (K complexes). Stage 3 is identi-
fied by the occurrence of relatively high amplitude (>75 PV) activity of 2 Hz or
slower, which is present between 20 and 50% of the time, while stage 4 is in-
dicated if such activity is present more than 507o of the time. The rapid eye
movement (REM) sleep stage, which has been highly associated with dreaming,
is =.characterized by EEG signals much like stage 1 in appearance, but it is
most notably differentiated by rapid, jerking-type eye movements as detected
by the EOG. A seventh category, stage 0, has been included in the analysis
schema to indicate interruption of data or loss of physiological signals.
Operation of the automatic onboard analysis equipment is indicated in a
simplified form in Fig. 5, showing the various logic .functions involving the
three input signals. In general, EEG alone was used to determine stages
awake and 1, 2, 3, and 4 of sleep. EEG and EOG signals detected stage
REM, and the EEG and accelerometer outputs recognized periods likely to
be contaminated by artifactual signals.
The EEG-analysis section (Fig. 5, Section 1) considered activity in the
0.7-13 Hz range derived from the paired central to paired occipital electrode
array. The circuit behaved as an amplitude-weighted frequency meter for the
dominant EEG activity (Frost, 1970). Each comparator was set to detect a
different EEG signal amplitude: high, or 100%; intermediate, or 20%; and
low, or 1%. The input EEG signal gain factor was adjusted once for each
E	
subject (determined during preflightbaseline studies), such that the average
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peak amplitude of the eyes -closed, waking EEG was made to fall midway
between levels 2 and 3, i. e., approximately 60%. Thus, higher-voltage
activity during sleep frequently crossed the third level, whereas the lower-
voltage signals of stage 1 usually exceeded only level 1 or 2. 	 9
s
The bistable circuit, associated with the level 1 and level 2 comparators,
.triggered the negative-pulse generator if, and only if, level 1 and level 2 were
crossed successively in a negative-going direction. As a result, the number of
constant-amplitude pulses produced by the negative-pulse generator was pro-
portional to the dominant frequency of the EEG and relatively independent of
minor inflections. The positive-pulse generator, with output one-half the
amplitude of the negative-pulse generator, was triggered each time the volt- 	 a
age exceeded level 3. The pulses from the two generators entered the mixer 	 a
amplifier, which supplied a composite . pulse form to the integrator circuit.
The integrator had a rise and fall time-constant of 10 sec, and consequently	 a
its output was a voltage level dependent upon the number and polarity of pulses
recorded during the preceding 10-sec epoch.
In terms of its influence on the integrator-circuit output, an EEG wave
of very low voltage, i.e. , not exceeding level 2, had zero value; an intermediate-
amplitude wave had maximum value (negative pulse); and a high-amplitude
wave (exceeding level 3) had a value of 50%, since it produced a negative
pulse and a positive pulse of one-half the amplitude. The schema included
effective utilization of the progressive decline in frequency and the general
increase in amplitude seen with increasing sleep depth. The individual's
EEG state therefore was expressed as a voltage level at the output of the
integrator. The awake state was associated with the highest output voltage,
and progressive stages of sleep were accompanied by correspondingly lower
output values.
The integrator output entered a series of comparator circuits 'in the out-
put section (Fig. 5, Section 4), where it was compared to previously determined
voltage ranges, each corresponding to one of the clinical stages. Thus, while
the EEG-analysis output remained within the range specified for a particular
sleep stage, a corresponding voltage was supplied to the output section of the
analyzer.
The EEG-analysis section classified stage REM sleep as either stage 1
or 2, due to its similarity in frequency and amplitude; however, true stage
REM is distinguished by the occurrence of bursts of rapid, jerking eye move-
nlents. Although these events are sporadic throughout a REM period, they
typically occur with a frequency of at least one recognizable event in each
30-sec epoch. During true stage 1-2 sleep, these events are absent. The
function of the REM-detection circuitry (Fig. 5, Section 3) was (1) detection
of events in the EOG channel which might be rapid eye movements, and
(2) indication of stage REM if such events occurred during an EEG period
representative of stage T or 2,
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EAmplified EOG activity entered the REM-detection section and passed
Qi	 through a filter that limited the response to the 2. 0-4. 0 Hz range, thereby
optimally separating true REMs from extraneous activity (e. g., EEG activity
detected by the EOG electrodes, slow eye movements, movement artifacts).
The signal next entered the EOG -transient-detector comparator, which de-
tected the occurrence of transient EOG wave forms exceeding a value equal
to 250% of either the average positive or the average negative voltage of the
simultaneously occurring EEG signal. (Averaging occurred continuously,
utilizing an RC circuit with a 15-sec time constant.) Thus, a change in EEG
background-activity level during the sleep period caused the EOG-detection
reference levels to reset automatically for proper relative values, thereby
minimizing the chance of false triggering by EEG wave forms that might have
been recorded by the EOG electrodes.
The EOG system also may have detected transient EEG events (such as
K complexes), and since these arise abruptly from the background, it may
have led to triggering of the EOG-transient detector in spite of the automatic
threshold-adjustment feature. Consequently, the EEG-transient-detector
circuitry sensed such events, operating on the EEG channel in a manner
identical to that of the EOG-transient detector, and recognized EEG events
which exceeded a value equivalent to 350% of the average positive or negative
EEG voltage.
The remainder of Section 3 of the logic circuitry then permitted an out-
put indication of stage REM only if the following criteria were met: (1) an EOG
event was detected by the EOG-transient detector, (2) no EEG event was de-
tected by the EEG-transient detector within a time window extending from 1. 4
sec before until 1.4 sec after the EOG event, and (3) the EEG-analysis section
indicated the presence of stage 1 or 2 of sleep. If these conditions were met,
a 30-sec output indication of stage REM occurred and was fed to the output
section, where its presence superseded the sleep-stage output of the EEG-
analysis section in terms of final output to the telemetry system. Since each
REM reset the 30-sec timer in the REM-detection section, if REMs were de-
tected with a frequency exceeding one per 30 sec, a continuous output indication
of stage REM occurred.
Although the data-acquisition methods were designed to minimize the
occurrence of artifactual signals, it was not possible to eliminate them com-
pletely. The majority are related to major body movements of the subject,
particularly when such motions result in changing forces exerted directly on
the cap recording electrodes. The artifact-detection circuitry (Fig. 5,
Section 2) was designed.
 to prevent signals with a high probability of artifactual
contamination from influencing the sleep -stage -determination systems.
The excessive-amplitude detector minimized the occurrence of false
sleep-stage determinations by disabling the EEG- analysis section and the
REM-detection section during and for 4 sec following the occurrence of an
-8
excessively high (i. e., nonphysiological) EEG signal, thus preventing a change
in the sleep-stage output section as a result of the artifact. A dual comparator
produced a trigger pulse if either the positive or the negative phase of the EEG-
signal voltage exceeded a value of 60076 (using the same relative amplitude
scale here as in the EEG-analysis section), which was considered to be in
excess of the usual physiological range. The resultant pulse started the 4-see
artifact-detection timer, which in turn operated an electronic switch for the
4-sec period. If the timer received trigger pulses at a rate equal to or ex-
ceeding one per 4 sec, the disable switch remained continuously activated.
F The accelerometer contained in the preamplifier served as another means
for detecting periods when artifactual contamination was highly probable. 	 Head
motion produced an output voltage roughly proportional to the rapidity of the
motion; thus, a relatively high voltage output from this device was more likely
to, be associated with artifact.	 The accelerometer comparator in the artifact-
detection section was set such that it was triggered by voltages equivalent to
changes in acceleration of approximately 0. 2 g in either the vertical or the
lateral axis.	 When triggered, the accelerometer comparator in turp -reset
`- --- the 4-sec artifact-detection timer, and the disable switch was consequently
activated for the duration of and for 4 sec following the movement.
Outputs from the six sleep-stage comparators and the REM indicator were
 - combined in the output section of the analysis circuitry (Fig. 5, Section 4) by an
s	 :, analog adder that provided the single output line to the spacecraft telemetry
system.	 The analyzer output flowed to the spacecraft telemetry system at a
rate of 1. 25 samples/sec.
	
During each pass over a ground receiving station,
the telemetered information updated a comprehensive display terminal at
Mission Control.
Ground-Based Data Analysis
Automatic Analysis Inflight
During a sleep monitoring session, true real-time data was available
only during the few minutes when the spacecraft passed over a ground tracking
station. Throughout the frequent periods when the spacecraft was out of
communication range, the sleep-stage data was accumulated by the spacecraft
telemetry recorder and transmitted to ground at a high rate during a subsequent
tracking-station pass. The tracking stations, in turn, relayed the telemetered
sleep-stage information to Mission Control. Consequently, the data ultimately
received during a sleep.period was somewhat sporadic, ranging from actual
real time to delays of up to several hours. Data-processing equipment in
Mission Control collated the incoming data so that the time relationships were
preserved, and eventually a complete tabulation of sleep stage versus elapsed
time evolved,
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Although data was telemetered at a rate of 1. 25 sleep-stage samples/
sec (75 samples/min), a subject's sleep stage does not typically change more
often than two or three times each minute, and it is often stable for several
minutes without change. The data-processing system was consequently
programmed to indicate only the time and the sleep stage when a change of
level occurred. The resultant listing of sleep-stage information versus
time was transferred to The Methodist Hospital, where the computer facilities
of the Neurophysiology Laboratories and the Baylor Institute of Computer
Science were employed to provide the final data analysis.
The end product was a compact graphic plot that showed the complete
profile of sleep stage versus time over the course of a sleep period. The
data was displayed at a horizontal resolution of approximately 2 in. /hr,
With a vertical span of approximately 4 in. , thereby providing an observer
With an overall summary or profile of the sleep period. A statistical sum-
mary of the all-night data was also supplied for each sleep period, and these
values for the following sleep parameters were included: total rest-period
time, total sleep time, total awake time, sleep latency, number of arousals,
accumulated time in each sleep stage, percentage of total sleep time occupied
by each sleep stage, and REM latency.
Visual Analysis Postflight
At the conclusion of each Skylab mission, the onboard data tapes were
returned by the crew, and this data was then analyzed by conventional visual
scoring techniques (Rechtschaffen and Kales, 1968) after playback onto a
graphic recorder. The various aspects of the sleep recordings and the
criteria used in scoring them follow.
(1) Total Rest Time: The period between the time of retiring to bed
until the time of arising for the day.
(2) Total Awake Time: The total time spent in the awake state between
the times of retiring to bed and arising for the day.
(3) 'Total Sleep Time: Total rest time minus total awake time.
(4) Sleep Latency: The elapsed time from retiring'to bed until the
subject attains a sleep stage other than stage 1 or awake.
(5) Sleep-Stage Percentage: The total time spent in a particular stage
of sleep divided by the total sleep time.
(6) REM Latency: The elapsed. time from sleep onset (occurrence of
a stage other than awake or stage 1 after retiring to bed) until
the onset of the first stage REM.
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(7) Number of Awakening s: The total number of discrete awake periods
occurring throughout the sleep period. (The period of wakefulness
at the beginning of the rest period and the final awakening of the
night were excluded from this measure.) A discrete awake period
is a period extending from the first appearance of stage awake
until the appearance of either stage 2, 3, 4, or REM. Thus, a
section of awake, followed by a section of stage 1, followed by
another awake section was classified as only one discrete awake
period. Stage awake was scored only if an arousal persisted for
at least 10 sec.
Experimental Design
One crew member participated in the sleep monitoring activities during
each Skylab flight. Preflight baseline data was obtained on the participating
subjects during three consecutive nights of sleep monitoring, using portable
apparatus functionally identical to the onboard hardware. The astronaut
studied during the 28-day mission was recorded in his own home two months
prior to launch, while the subjects of the 59- and 84-day missions were
monitored in the preflight quarantine facility two weeks before their respective
launches. In addition, a standard clinical electroencephalogram was performed
on each subject prior to the flight to permit precise EEG-amplitude determinations
for calibration of the flight hardware.
Inflight monitoring was accomplished during 12 selected nights of the 28-
day mission (nights 5, 6, 7, 10, 11, 15, 17, 19, 21, 24, 25, and 26), during
20 nights of the 59-day mission (nights 7, 8, 9, 12, 15, 18, 21, 24, 27, 29,
33, 36, 39, 42, 45, 48, 52, 55, 56, and 57), and during 18 nights of the 84-day
flight (nights 3, 4, 10, 14, 19, 24, 29, 34, 40, 45, 50, 55, 60, 72, 77, 80, 81,
and 82). Operational factors associated with the activation and function of
various spacecraft systems prevented recordings during the initial period of
each flight.
Crew bedtime was typically 10 p.m., and the scheduled sleep period
terminated at 6 a.m. , although occasional deviations from this schedule were
necessitated by work requirements not associated with the sleep monitoring
experiment. During the last week of the 28- and 59-day missions, sleeping
schedules were adjusted forward by a total of four hours (i. e. , typical bedtime
became 6 p.m.). An adjustment of two hours was made on days 20 and 22 of
the 28-day mission, and there was a similar change of two hours on days 51
and 53 of the 59-day mission. During the 84-day mission, schedule altera-
j
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tions were made during the last three days only, and consequently only one
day (day 82) of sleep monitoring was affected. On this day the bedtime was
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advanced approximately two hours (to approximately 8 p.m.), and the sub -
ject was permitted a 10-hr total rest time (i. e., the time of awakening r'e
mained approximately 6 a.m.). These schedule alterations were necessitated
A
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by the activities associated with splashdown and recovery operations, which
required early awakening on the final day of the mission.
Upon return to Earth, postflight baseline studies were performed on each
sleep monitoring participant. After the 28-day mission, recordings were done
on nights 4, 6, and 8, and in the case of the 59-day mission, on the second,
fourth, and sixth nights ,following splashdown. Following the 84-day mission,
recordings were made on the first, second, and sixth nights.
Operational Factors
A period of elevated temperatures in the Skylab workshop prior to the
arrival of the first crew (a result of loss of a portion of the solar heat shield
during launch) resulted in two problems with respect to the sleep monitoring
activities scheduled for the first mission. A number of the recording-cap
electrodes suffered partial dehydration, and as a result, most of the data was
lost during one scheduled recording night. In addition, the analog-tape record-
ing system was damaged, and only two nights were successfully recorded.
The recording-cap problem during the first (28-day) mission necessitated
use of caps intended for use on future flights and which had been stored in a
cooler location on board the spacecraft.
The crew of the second manned Skylab mission (59 days) was supplied
with a repair kit, which permitted refurbishment of the damaged recording
caps by injection of supplementary electrolyte gel prior to use. In addition,
repair of the recording system was attempted prior to the first night of re-
cording. In general, these steps were successful, although one additional
night was lost during the 59-day mission due to recording cap problems,
and six nights of tape-recorded data were lost near the end of the mission
when the recording system again failed.
Prior to launch of the Skylab workshop, the plan was to monitor sleep
during only the .first and second manned missions, and consequently only
enough recording caps were placed on board to provide one for each scheduled
night. When the schedule was later changed to include sleep monitoring on
the final, or 84-day, flight, there were not enough caps remaining on board
to permit use of a new unit for each recording session. Instead, the subject
reused a single cap several times and injected additional electrolyte gel into
the sponge electrodes before donning the cap each night. This technique was
satisfactory, and the data quality remained high. Of the 18 sessions attempted
during the 84-day mission, 17 were successfully accomplished. One night
(night 50) was lost when power to the onboard hardware was lose after approxi-
mately two hours of recording.
A significant data loss also occurred on two additional nights of the
F	 28-day mission and on one other night of the 59-day mission, stemming
S
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from ground-based problems in the data-processing system.
In spite of the unforeseen problems, however, successful near real-
time monitoring was accomplished on nine of the 12 attempted recording
nights during the 28 -day mission, on 18 of the 20 nights attempted on the
59-day mission, and on 17 of the 18 attempted sessions of the 84-day flight.
Postflight return of the analog tapes permitted visual confirmation of the
results on two of the nine nights of the 28 -day mission, on 12 of the 18 nights
of the 59-day mission, and on 17 of the 18 nights of the 84-day mission.
Statistical Analysis
The final results described below represent the best available estimates
of the various sleep parameters. The results are, when possible, those ob-
tained by visual analysis of the tape-recorded EEG, EOG, and head-motion
signals, since this method is considered the most reliable and the least in-
fluenced by various artifactual components that may be present. In the
instances where this was not possible, due to loss of recorded data on several
nights, the results of onboard automatic analysis have been utilized after appli-
cation of certain corrective factors based upon past performance of the system
and, in the case of the 59-day flight, upon correlation of the inflight results
with those of visual analysis for the nights on which both types of information
were available.
Modification of Automatic-Analysis Results
The uncorrected results of automatic analysis consistently underestimated
stage REM sleep. This occurred because the criteria for continuous stage REM
indication used by the automatic system included the occurrence of at least one
detectable rapid eye motion per 30-sec epoch. If such an eye motion did not
occur, the output reverted to stage 1 or 2, as determined by EEG criteria
alone. In most individuals, true stage REM occasionally occurs for periods
longer than 30 sec in the absence of eye motion of sufficient amplitude to be
detected by the automatic circuitry. Typically, then, the automatic system's
output during a continuous stage REM period fluctuated between stages 1, REM,
and 2. Such periods usually were readily identified by inspection of the plotted
sleep profile. When the automatic data was modified by the assignment to
stage REM of all time within such a period, the overall results were significantly
enhanced. Such modification introduces an element of subjectivity into otherwise
objective data; however, we believe this is justified in this case, since past ex-
perience has confirmed its validity.
Other than eliminating certain obviously artifactual sections of data (e. g.
sections near the start of each sleep period, associated with cap-donning and
electrode-testing procedures), the REM-modification step was the only corrective
r
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factor instituted during the inflight portions of the Skylab missions.
Reliability of Automatic-Analysis Results
After the 59-day mission, we compared the results of modified inflight
analysis with those of visual analysis of the taped data for 11 of the first 12
recording nights. The average (mean) error of automatic analysis based upon
visually determined total rest-period time was as follows: total rest-period
time, +17o; total sleep time, +4 01o; sleep latency, -0. 3%. The average (mean)
error of automatic analysis in sleep-stage determination (as compared to the
same visually determined parameters) was as follows: % stage 1, +5. 67o;
stage 2, -0. 476; % stage 3, -10. 67o; % stage 4, -0. 77o; % stage REM, +6. 176•
In most cases, then, automatic analysis gave satisfactory estimates of
the actual value. The worst case, % stage 3 sleep, was apparently a result of
the particular subject's sleeping pattern, in which a large proportion of the
misclassified epochs were borderline in terms of stage 2 versus stage 3. The
underestimation was consistent throughout all 11 comparison nights. The %u
stage REM overestimation, on the other hand, was not consistent and appeared
to result solely from the inherent limitations of the automatic-analysis scheme
in detecting this stage and in rejecting certain artifacts.
Similar comparisons between visual and automatic analysis were made
following the 84-day flight for the 17 successful monitoring sessions. In this
case, the average (mean) error of automatic analysis compared to the visually
determined total rest-period time was as follows: total rest-period time,
+1'. 276 ; total sleep time, +4. 4%; sleep latency, +0. 9 76. The average error of
automatic analysis in sleep-stage determination (as compared to the visually
determined parameters) was as follows: % stage 1, +1. 676; 0/6 stage 2, -11.4°16;
stage 3, +7. 97o; % stage 4, +6. 1%6; % stage REM, -4. 27o.
Correction and Regression Techniques
Regression analysis, after correlation of automatic and visual results,
provided a means for further modifying the results of automatic analysis for
those six nights of the 59 -day mission unconfirmed by visual analysis (i. e.,
nights 42, 45, 48, 52, 56, and 57, for which the analog-tape data was lost).
As noted above, the overall correlation between visual and automatic
results for stage REM percentage was low and consequently could not be
utilized for reliable prediction of the remaining six values. However, it
was determined that stage REM values below 20 %, as indicated by automatic
analysis, were better correlated with visual results; consequently, regression
analysis for this stage was based upon correlations of only six of the 11 nights
(discarding nights 7, 8, 9, 12, and 29)• Corrected REM values were thus
predicted for five of the six remaining nights, discarding the value (30.4 °10)
for day 48, which exceeded 20%.
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These statistical maneuvers provided a consistent means for utilizing
all the available information. The values obtained are included in the results
presented below and were subjected to further statistical analysis along with
the visual-analysis results, although it was determined that the overall signifi-
cance of the results was the same, whether or not these values were included.
Analysis of Variance
Y
Finally, for each mission, preflight, inflight, and postflight conditions
for each parameter were treated by an analysis of variance. A posteriori
comparisons were made in cases where the overall F test reached conventional
levels of statistical significance (p <0.05).
In summary, with respect to the final results outlined below (Results
Section), of the nine nights recorded during the 28-day mission, only the
first two are based upon visual analysis. The remainder are based upon
the modified results of automatic analysis. For the 59-day mission, the
results of the first 12 nights are based upon visual analysis, while the last
sic are automatic results modified both inflight in terms of REM period and
postflight by the application of corrective factors based upon visual/ automatic
comparison on the first 12 nights. For the 84-day mission, all 17 nights are
based upon the results of visual analysis.
Data Format
	 1
The data obtained during the three Skylab sleep monitoring experiments
is presented in three forms: (1) sleep profiles showing the entire data set for
each night in the form of a plot of sleep stage versus time; (2) tables in which
parameters derived from the sleep profiles are listed for each recording session
of the mission; and (3) graphs in which selected parameters are plotted versus
mission day to illustrate trends and to compare data from the three flights.
Sleep Profiles
Preflight Baseline Studies
These profiles are based upon human visual analysis of the data obtained
s	 during the three preflight baseline studies of each participating crew member.
Data for the 28-day mission, obtained two months prior to launch, is shown in
-Fig. 6. Results for the 59-day flight, obtained two weeks prior to launch, are
illustrated in Fig. 7, and those for the 84-day mission, also obtained two weeks
prior to launch, are presented in Fig. 8.
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Inflight Data
The sleep profiles showing inflight data are of two types: those based
upon onboard automatic analysis and obtained by telemetry in near real-time,
and those obtained postflight by human visual analysis of the tape-recorded
flight data returned by the crews.
Automatic-Analysis Profiles. The data presented in these plots illustrates
the complete results of automatic analysis for the particular night under study.
Occasional gaps in the plots indicate periods when the telemetry signal was lost(due to difficulties in the tracking and data-processing systems). The raw data
presented in these illustrations was, as explained in the section on modification
of automatic-analysis results, above, subjected to further modification tech-
niques in order to eliminate artifacts and to increase the reliability of the
stage REM indication. The areas subjected to modification are indicated by
horizontal lines above the data plots (labeled M on the vertical scale), and the
type of modification is indicated by the letter above the horizontal line. Thus,
a line labeled R signifies that all data below the line was assigned to stage REM,
regardless of the actual stage shown in the raw-data plot. Similarly, lines -
labeled A indicate that all data below the line is reassigned to the awake state.
These plots, with the indicated modifications, were utilized for sleep
assessment during the inflight period of each mission, and they were the best
estimate of the individual sleep characteristics prior to the analysis of the
analog tapes after the conclusion of the mission. Data for the 28-day mission
is presented in Figs. 9-12. Day 5 was of poor quality due to recording
-cap
problems (see above, Operational Factors). Day 7 was uninterpretable due to
excessive dat<,-loss periods. Day 11 was degraded because of further recording
cap problems, and day 25 was incomplete, since the subject neglected to don the
recording cap at the start of the actual sleep period.
Automatic -analysis results for the 59-day mission are shown in Figs. 13Y	 g19. Day 39 was lost due to faulty electrode-cap function.
The results for the 84-day mission are presented in Figs. 20-26. Data
t	 was last, on day 50 after two hours, due to a power loss in the onboard hardware.
r
	
	 Visual Analysis. These profiles are the result of human visual analysis
of the data played back from the onboard analog-tape recording system. These
tapes were returned by the crew at the end of each mission, and the data thus
serves as a check on the results obtained by automatic analysis during the
mission.
The results for the 28-day mission are shown in Fig. 27 (days 5 and 6);
data for the remaining 10 nights was lost due to a tape-recorder malfunction.
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Visual-analysis results for the 59-day flight are shown in Figs. 28-32
(days 7, 8, 9, 12, 15, 18, 21, 24, 27, 29, 33, and 36). Results for the latter
portion of the mission (days 35, 42, 45, 48, 52, 55, 56, and 57) were lost due
town onboard tape-recorder malfunction. Visual-analysis profiles for the 84-
day mission are illustrated in Figs. 33-39.
Postflight Baseline Studies
As in the preflight studies, these profiles are based upon human visual
analysis of the data obtained during three postflight monitoring sessions on
each of the Skylab sleep monitoring experiment subjects. Following the 28-
day mission, as shown in Fig. 40, data was obtained on the fourth (R+3),
sixth (R+5), and eighth (R+7) nights following recovery. After the 59-day
flight (Fig. 41), recordings were made on nights 2 (R+1), 4 (R+3), and 6
(R+5). The results for night 2 were incomplete, since the subject terminated
recording after approximately four hours due to discomfort from the recording
cap. Following the 84-day mission (Fig. 42), the subject was studied on the
first (R+O), second (R+1), and sixth (R+5) nights.
Tables
The basic sleep data from each all-night sleep profile, described above,
was subjected to further ground-based computer analysis in order to determine
selective parameters of value in estimating the overall quantity and quality of
sleep during the mission. In all cases, the results of visual analysis (V) were
used whenever this information was available. For the case of the 28 -day
mission (Table I), visual-analysis results were available for the first two
nights only. For the final seven nights, the data is based upon the modified
results of automatic analysis (MA), as shown in Figs. 10-12.
During the 59-day mission (Table II), a tape-recorder malfunction re-
sulted in data loss for visual analysis on days 39 through 57. The data shown
for these nights in Table II was based upon modified automatic-analysis
(i. e., Figs. 17-19) results, which were further enhanced by the correlation
and regression analysis technique described previously (MCA).
All data in Table III for the 84-day mission is based upon visual analysis.
_ The average values shown in the tables represent the means of the values
in each category, preflight, inflight, and postflight.
Graphs
The graphs of individual sleep parameters are utilized below in the dis-
cussion of changes in sleep characteristics during Skylab. These plotted values
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are, in all instances, the same as those indicated in the tables for the corre-
sponding mission.
Data Quality
.fi	
Data quality, as evaluated by visual inspection of the signals played back
i from the analog tapes returned at the conclusion of each mission, was generally
excellent. Although recorder malfunctions occurred during the 28- and 59-day
missions, the data recorded prior to the failures was, in both instances, of
high quality. During the 84-day flight, the recorded signals were of clinical
quality throughout the mission.
Selected examples of the EEG, EOG, and head-motion signals as played
back from the onboard capes are shown in Figs. 55-60. Figs. 55 and 56 illus-
trate the transition from the awake, alert state through the various stages of
sleep for the scientist-pilot on day 6 of the 28-day mission. A similar series
for the subject of the 59-day flight is illustrated in Figs. 57 and 58, which were
obtained during day 29. Examples from day 3 of the 84-day mission are shown
in Figs. 59 and 60.
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Sleep Latency
Sleep latency is the amount of elapsed time from the onset of the sleep
period (i. e. , bedtime) until the first appearance of stage 2 sleep. Sleep-latency
	
characteristics observed during the three Skylab missions are summarized in 	 !`Fig. 43. Average inflight, preflight, and postflight figures for this parameter
are indicated in Tables I, II, and III. Sleep latency varied considerably during
the 28 -day mission (Fig. 43A), ranging from a low value of 3. 6 minutes on day
21 to a maximum value of 45 minutes on day 19. Day 19 (Fig. 11) was, however,
the only instance in which the latency exceeded the preflight values, and the aver -
age inflight value of 18 minutes actually represents a decrease of 20 minutes as
compared to the preflight average of 37. 8 minutes. Postflight values were all
relatively low but well within the inflight range. Statistically, the inflight and
postflight latencies were less than the preflight values (p <0.01)
No statistically significant changes in sleep latency were noted during the
59 -day mission, as indicated in Fig. 43B, although on several days the values
were somewhat above the preflight average of 12 minutes. This parameter
.ranged from a low of 4 minutes on day 21 to a maximum of 24 minutes on day
45. A cyclic fluctuation in sleep latency was suggested, with maxima near
days 10,- 29, 45, and 52. The inflight average value (12.6 minutes), however,'
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was almost exactly the same as the preflight value. The postflight 'latencies,
averaging 9.6 minutes, are only slightly less than either the pre- or inflight
measurements -
Sleep latency during the 84-day mission averaged almost the same in-
flight (15.6 minutes) as preflight (16. 2 minutes), but it dropped to an average
of 7.8 minutes postflight (Table III). Although the averages do not reflect a
significant change, inspection of Fig. 43C reveals a preponderance of longer
latencies in the first half of the mission and a decline as the flight progressed.
The average value for the first half (days 3 through 40) was 21. 4 minutes, while
that for the latter half (days 45 through 82) was 9. 7 minutes.
In general then, there was no evidence of difficulty in falling asleep in
either the 28- or 59-day mission, while in the 84-day flight, values somewhat
above baseline were seen in the first half of the mission but declined to normal
or below normal in the final portion...
Sleep Time
A commonly used measure of sleep adequacy is the total sleep time ob-
tained in a given sleep period (i. e. , total rest-period time minus total time
spent awake). Fig. 44 illustrates the total rest-period length (overall ampli-
tude of vertical bars), total sleep time (solid.portion of bars), and total awake
time (dashed portion of bars) for each Skylab recording night and for the pre-
and postflight baseline studies.
It is apparent that in the 28 -day mission (Fig. 44A), there was a reduc-
tion of total sleep time throughout the inflight period as compared to the pre-
and postflight studies. Postflight, total sleep time was significantly greater
than the pre- and inflight values (p <0. 05 and 0. 01, respectively). As indicated
in Table I, the inflight average of 6. 0 hours is almost one hour less than the
preflight value of 6. 9 hours and more than tv,*o hours less than the postflight
average (8-5 hours). This decrease in sleep time, however, was due not to an
unusual amount of time spent in the awake state but to a reduction in the total
rest-peritad time itself. The subject thus slept quite well on most nights while
he was in !red; however, he did not spend as much time in bed as he did during
studies either before or after the mission.
The postflight, average value for total rest-period time (8. 9 hours) was
significantly higher than the inflight average ( p
 <0. 01) but did not differ signifi
cantly from the preflight value.
No significant changes in the total sleep/total rest characteristics were
obtained during the 59-day mission, as shown graphically in Fig. 44B. The
total rest time (overall height of bars, Fib. 44B), which. averaged 7. 3 hours
inflight (Table II), was only slightly lower than eitherthe preflight average of
7.5 hours or thepostflight, value of 7.8 hours. In terms of total sleep time
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i(solid bars, Fig. 44B), although there was considerable fluctuation, only one
day (52) was below the range established during the preflight series, and the
subject obtained in excess of 5 hours' sleep on all other nights. The inflight
average value of 6. 3 hours (Table II) is nearly the same as the preflight
average (6. 4 hours) and slightly lower than the postflight results (average,	 R
6. 6 hours) .
A wide range of variation in the total rest and total sleep times was
seen during the 84-day mission (Fig. 44C). Total rest time ranged from
a.minimum of 6.4 hours on day 10 to a maximum of 9.8 hours on days 24
and 82. This parameter averaged 8. 06 hours preflight, dropped by 30 min-
utes to 7. 56 hours inflight, and then rose to 7.67 hours postflight. Although
most of the inflight period was marked by considerable variation from one
recording session to the next, there was a consistently lowered total rest
time during the observations of the first 19 days. The five values of this
period averaged 6. 86 hours, or 1. 2 hours below the preflight average.
Total sleep time tended to parallel total rest time, and thus long periods
of time spent awake during the night were, in this mission as in the others,
rare. Sleep time ranged from a low of 4.88 hours on day 4 to a high of 9. 37
hours on day 24. The inflight average value of 6. 69 hours is about 36 minutes
below the preflight average of 7. 29 hours but is approximately 10 minutes
higher than the postflight result of 6. 53 hours. As in the case of total rest
time, total sleep time also was considerably lower during the .first-l9-day
period. During this time, the average value was 5. 87 hours, or 1. 42 hours
below the preflight average.
Of interest is that while the initial 19-day period was characterized by a
reduced time in bed and correspondingly reduced total rest time, it was also
marked by a higher value for total awake time (0. 99 hours average) compared
to either the preflight average (0. 77 hours) or the overall inflight average (0.87
hours).
a
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Sleep-Stage Characteristics
Sleep-stage characteristics for the three missions, expressed as per-
centages of the total sleep time for each recording night, are illustrated in
Figs. 45-47. Average percent figures for the various stages in the preflight,
inflight, and postflight periods are listed in Tables I, II, and III. Comparisons
of individual stage characteristics for the three missions are illustrated in
Figs. 48-52.
If the average values are considered, stages 1, 2, 3, and REM were not
significantly altered during the inflight period of the 28-day mission (Fig. 45).
Stage 1 occupied 5. 316 of the total sleep time preflight and averaged 6% inflight
and 5. 176 postflight. The day-to-day inflight characteristics show a considerable
20
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fluctuation in stage 1 percent, with a tendency toward slightly decreased values
in the latter portions of the flight (days 19 through 26). Stage 3, averaging
14. 8% in the preflight period, rose slightly to an average of 16. 0% inflight
and dropped to 1.2-276 postflight. As seen in Fig. 45, a small increase in
the stage 3 percent average was largely a result of moderate increases in
j	 this stage on days 24 and 26 at the end of the mission. Stage REM decreased
y ► 	 only slightly from a 22. 2% preflight average to 17. 9% inflight, although again
there was considerable variation throughout the flight, with some tendency
toward a more marked decrease near.the end of the mission. The postflight
stage REM average (25.076) was somewhat higher than either the pre- or in-
flight values, but it did not attain statistical significance.
F
Fairly clear-cut changes were seen in stage 2 and stage 4 percentages.
In both cases, the most obvious alterations were seen in the last few days of
the flight. Stage 2 dropped from an average of 54. 8% preflight to 43. 4% in-
flight, returning to 56. 6% postflight. These differences, however, were not
significant. Similarly, stage 4 rose from 2. 9% preflight to 16. 776 inflight,
then dropped significantly (p <0. 05) postflight to 1. 1%.
Thus, the 28-day mission was characterized by increased percentages
of stages 3 and 4 and corresponding decreases of stages REM, 1, and 2, with
the alterations confined primarily to the last few days of the .flight.
Sleep-stage features for the 59-day mission are illustrated in Fig. 46,
and average values are tabulated in Table II. Stage 1, averaging 8. 8% pre-
flight, showed considerable variation inflight but averaged almost the same
0 (8. 9%). The postflight average value of 10. 2% was only slightly above the in-
,-	 flight result. Stage 2 remained fairly consistent throughout (preflight, 56. 3%;
inflight, 59.7%; postflight, 57.8%). Thus, neither stage 1 nor stage 2 changed
significantly. Stage 3 was similar inflight (17. 5%) and preflight (17.4%) and also
exhibited a change near the termination of the flight; tending to increase slightly.
The postflight average of 10. 1%, however, was significantly lower (p <0. 01) than
either the pre- or inflight values. This subject showed very little stage 4 sleep
in his preflight study (2.876), and this parameter decreased significantly (P<0. 05)
inflight (1. 4%) and postflight (0. 416) (p <0. 05). Stage REM showed the greatest
alteration, dropping from 14. 7% during the preflight baseline series to 12. 176
inflight, and then rising significantly (p <0. 01) to 21. 6% postflight. This post-
flight increase in REM was also significantly greater than the preflight value
(p <0. 05). The REM decrease seen inflight was most prominent in the final
phase of the study (days 52, 56, and 57).
Sleep-stage characteristics for the 84-day flight are summarized in Fig.
47, and the average values are tabulated in Table III. Stage 1, averaging 8. 9%
preflight, dropped inflight to 6. 8%, then rose postflight to 9. 4%, a value slightly
higher than the preflight average. There were no-clear-cut trends discernible
over the inflight course of the mission. The stage 2 values were relatively'
consistent during the inflight period, and the average value of 58. 576
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identical to the preflight average. Postflight, stage 2 showed a small increase,
averaging 66. 1% for the three days. As indicated in Fig. 47, the stage 2 values
of the first two postflight days were significantly higher than any of the values
preflight or inflight. Stage 3 was not significantly different inflight (8. 8%) as
compared to the preflight value (7. 1%). Postflight, however, this parameter
fell to an average of 2. 711, with all three values .falling well below the pre-
and inflight averages. This subject showed very little stage 4 preflight,
averaging only 0. 2%, and maintained a low level throughout the flight, with
the inflight average at 0. 577. There was a further reduction postflight, with
the average value less than 0. 17o. Stage REM percent averaged 25. 3 preflight,
and the inflight average remained at 25. 37o. There was considerable variation
in this parameter over the course of the mission, however, but no definite
trends were observed. Although the postflight average of 21. 8% was slightly
lower than either the preflight or inflight average value, it is obvious (Fig. 47)
that this parameter was not stable in the postflight period. The value of 12. 1%
on the first postflight night is significantly lower than any of the pre- or inflight
values for this characteristic. On the other hand, the value of 34. 676 seen on
the sixth postflight night is considerably higher than any of the values seen
preflight or inflight.
REM Latency
REM latency is the elapsed time from sleep onset (i. e. , the first appear-
ance of stage 2 sleep) until the onset of the first stage REM period of the night.
Because of the relative unreliability of this measurement when derived from
the results of automatic analysis, only the values obtained from visual analysis
have been reported below.
Compared to preflight values, this measure was shortened during the
postflight periods of the 28- and 59-day missions. During the 28-day flight
(Fig. 53A and Table I), the REM latency averaged 1. 5 hours preflight and
1. 1 hours postflight, or a decrease of 24 minutes. Although substantial, this
decrease was not statistically significant. The phenomenon was more apparent
during the 59-day mission, as illustrated in Fig. 53B. In the preflight baseline
period, the values ranged from 1. 6 to 2. 2 hours, with an average latency of 1. 9
hours (see Table II). The inflight values showed considerable .fluctuation, but
the average of 2. 1 hours was not significantly different compared to the preflight
results. In the postflight period, however, the latency dropped to 0. 9 hours,
which represented a decrease of 1 hour below the preflight findings. This post-
flight- REM latency was significantly (p < 0. 01) less than both pre- and inflight
values.
REM latencies during the 84-day mission (Fig. 53C and Table III) showed
little change in the inflight period compared to either pre- or postflight studies.
The inflight average value of 1. 31 hours is not significantly different from the
2.2
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1. 47 hours figure seen preflight, while the value of 1.46 hours seen postflight
is almost identical to the preflight result. Note that the first postflight night
exhibited a relatively long REM latency, while the latter two postflight nights
were marked by much shorter periods.
REM-Period Characteristics
In order to determine the influence of spaceflight upon the cyclical or
periodic nature of sleep, the temporal occurrence of REM episodes throughout
the night was studied. The length of each REM period was determined, and the
average value for the parameters was found for each preflight, inflight, and
postflight night for which visually analyzed data was available. Similarly,
each REM-cycle length was determined (i. e., the elapsed time between the
onset of sleep and the onset of the first REM period and, subsequently, the
elapsed time between the onset of one REM period and the onset of the next),
and the average value of this measure for each night was calculated. Data
for the three missions is presented in Tables IV-VI.
No significant alterations in these parameters were seen during or follow-
ing the 28-day flight (see Table IV).
During the 59-day mission (Table V) and postflight, there was a small
reduction in the average REM-period length (20. 7 minutes preflight, 16. 0
minutes inflight, and 16. 2 minutes postflight), and several inflight daily aver-
age values fell considerably below the range seen preflight. A similar trend
was seen with respect to the REM-cycle length, which averaged 128. 3 minutes
preflight, 102. 5 minutes inflight, and 73. 1 minutes postflight.
The 84-day mission results were similar to those of the 59-day flight in
that a small reduction in both the average REM period and REM-cycle length
was observed (Table VI). REM-period length, which averaged 31 minutes pre-
flight, was 22. 6 minutes inflight and 20. 6 minutes postflight. The REM-cycle
length, averaging 108 minutes preflight, dropped to 81. 8 minutes inflight and
was 90 minutes postflight.
Number of Awakenings
The number of awakenings per night was calculated for the data based
upon human visual analysis only, and this information is presented compara-
tively in Fig. 54.
The 28-day flight was characterized in the preflight period by an average
of 19. 7 awakenings per night, with a range of 16 to 24 (Table I). The postflight
average was 22, with a range of 20 to 26. Although only two inflight nights are
available for comparison, in both instances the number of awakenings was be
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the pre- and postflight levels.
The number of awakenings during the preflight baseline series for the
59-day mission .ranged from 34 to 51, with an average of 40. 7 (Table II).
inflight a greater range was seen, extending from a low of eight on day 33
to a high of 70 on day 9, with an average of 39. 3. Postflight the average
number of awakenings dropped to 28. 5, with a range of 26 to 31. The number
of arousals seen during the inflight portion of this mission peaked at day 9 and
tended to decline toward baseline or sub-baseline levels as the flight pro-
gressed.
In the case of the 84-day mission (Table III), the number of arousals
declined from a preflight average of 20.7 (20 to 21) to an inflight average
value of 12, with a range of 6 to 22. Postflight, the level rose to an average
of 18. 7, with a range of 11 to 24. Although the inflight period was character-
ized by considerable variation in this measure, there was no consistent trend
noticeable.
SUBJECTIVE REPORTS
r
Although subjective reports of sleep characteristics are often not quan-
titatively correct when compared to the results of objective sleep monitoring
studies utilizing EEG and EOG, in many instances they do reflect an accurate
estimate of the overall quality. During Skylab, there were numerous refer-
ences to sleep made by the crew members in their conversations with Mission
Control, and these are preserved in the transcripts of spacecraft-to-ground
communications. In addition, comments concerning sleep were made spon-
taneously and in response to specific questions during the postflight debriefing
sessions held after each mission. During the 59- and 84-day missions, sleep
{
	
	
logs were kept by all three crewmen, in which they recorded their estimates
	 r
of the quantity and quality of each night of sleep. Data gathered from these
sources is summarized below for each mission. Although the M133 Sleep
Monitoring Experiment was performed by the scientist-pilot only, subjective
	
R
observations made by all three crewmen are included.
28 -Day Mission
Subjective sleep logs were not maintained during this mission as they
were during the 59- and 84-day flights; in general the crew members felt
that sleep was adequate, and no particular problems of a long-term nature
{
	
	 were reported. All three astronauts felt that they slept less inflight than
they had been accustomed to on the ground, but they did not feel that the re-
duction in time was detrimental. ; In fact, they did not feel that they required
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more sleep than they actually obtained. The extra time was utilized for reading
or other personal recreation, and the eight-hour total rest period was felt to be
beneficial even though not always used for sleep.
The sleep-restraint system was considered to be quite functional, and
according to the CDR it was a significant improvement over the methods utilized
in prior spacecraft.
The occasional periods of elevated temperature present in Skylab were
considered to have interfered with sleep to some extent, and the sporadic noise
generated by certain equipment on board occasionally resulted in brief arousals
from sleep.
The M133 system caused no particular problems, although the SPT felt
that the recording cap resulted in some mild discomfort, and this may have
occasionally influenced sleep characteristics.
59-Day Mission
The crewmen were satisfied with the functioning of the sleep-restraint
system and felt that it, in some respects, simulated the pressure sensations
of 1 g. In general, they felt that sleep was better when the Skylab temperature
r ,..
	
	
was cooler. There were complaints about the lack of soundproofing and light
proofing in the individual sleep compartments: Sleep was difficult if one crew-
man was active while the others attempted to sleep.
The SPT commented on how pleasant it was to sleep in space, and he felt
that he was receiving approximately the same amount of sleep as he was accus-
tomed to on the ground. He also commented that on the few nights when he did
not sleep well, or long enough, the lack of sleep seemed to affect him more the
next day than a comparable sleep loss would have on the ground. A similar
comment was made by the CDR, who noted that on the ground he might miss
considerable sleep during the week and yet make it up on the weekends without its
affecting his performance, but in space it seemed to affect him immediately
the next day.
All crewmen, in general, felt that they slept well. Falling asleep was not
a problem, and the SPT commented that he almost enjoyed waking up because he
then had the pleasure of returning to sleep. The Skylab equipment noises were
somewhat bothersome during the first few nights in space
It was noted that the M133 cap was more bothersome in the postflight period
due to the pressure on the head. The SPT felt that he lost perhaps an hour of
sleep during the R+l study due to the discomfort.
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The SPT commented that he rarely felt as tired at the end of a day in
space as he might have after a comparable day on Earth. He went to bed
because he felt that he needed the sleep, but he usually had the impression
that he could easily have stayed awake longer. The CDR, however, stated
that he did feel tired at the end of the day, and he had not noticed a difference
in this aspect peculiar to spaceflight.
The subjective reports of sleep estimates for each day of the mission,
as recorded in the crew logs, are presented in Table VII for all three crew-
men.. Medication used during the 24 hours preceding the sleep period is also
indicated in this table. A comparison of the objective (M133) data with the
SPT's estimates is illustrated graphically in Fig. 61.
34-Day Mission
The three crew members were unanimous in their opinions that sleep
quality was greatly enhanced by the sleeping bag restraint systems. Attempts
were made by at least two of the astronauts (SPT and CDR) to sleep without
restraints on several occasions while drifting freely. Although they felt that
they did sleep to some extent under this condition, sleep was intermittent and
was not considered to be sound. The restraints apparently produced a sensation
somewhat similar to gravity, and this contributed to the ability to fall asleep
and remain asleep. In addition, when drifting freely there was intermittent
contact with various items which apparently served as arousal stimuli.
The SPT reported no difficulty in operation of the M133 system and ex-
pressed the opinion that the recording cap did not interfere with his sleep. He
found the cap more comfortable in zero g than he had under 1 g conditions. The
only significant problem noted with respect to the M133 Experiment was the
necessity to clean excess electrolyte gel out of his hair each morning follow-
ing use of the cap, a job requiring approximately .five minutes. He experienced
some difficulty in plugging the cap umbilical cable back into the control unit when
it was necessary to get up during the night.
Occasional and intermittent bouts of insomnia were reported by all three
astronauts, especially during the first 28 days of the mission. The crew mem-
bers attributed this, in part, to unusually long working hours (several 18 -hour
workdays) in the early days of the mission, with insufficient time in the presleep
period to relax and "wind down." No specific problems were delineated, and they
experienced at various times difficulty in falling asleep, arousals from sleep,
with a prolonged time necessary to return to sleep, and early awakenings. The
SPT apparently experienced the most-pronounced difficulty, primarily during,
the first 28 days; then he began to sleep fairly well, with only sporadic problems
for the remainder of the flight. However, he felt strongly that the problems en-
countered were "man made" (i. e. , due to ovexscheduling_problems), and he did
not feel that the zero g environment per se was a factor. Dalmane and
n
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promethazine/ephedrine were occasionally utilized to promote sleep, with the
promethazine /ephedrine providing the best subjective response.
All crewmen were asked to report any changes in their sleep character-
7 istics which had occurred postflight as opposed to pre- and inflight. 	 The SPT
felt that he had been much more conscious of dreaming postflight, and he felt
that he did not dream noticeably inflight. 	 The CDR noted that during the first
two-thirds of the mission his dreams were 1 g but changed to zero g during
the last third of the flight. 	 The PLT did not routinely recall dreams pre-f flight and noted no change in this characteristic either inflight or postflight.
During this mission, each crew member routinely reported his own
4 estimate of his sleeping quantity and quality upon arising each morning.
f These results are presented in Table VIII for the CDR, Table IX for the
PLT, and Table X for the SPT.
	
In addition to sleeping characteristics,
{ each table indicates the medication taken by each crewman over the course
of the mission. 	 The information shown in Table VIII (CDR) is summarized
graphically in Fig. 62, while that of Table IX (PLT) is plotted in Fig. 63.
A similar graphic representation for the SPT (Table X and Fig. 64) also in-
cludes, for ease of comparison, the actual sleep and rest times as determined
objectively from the M133 data. 	 is	 inIt	 apparent that	 almost every instance,
on days when M133 data was available, the subject's estimates of total sleep
ytime corresponded closely to the subjective measure of total bed time.
	 In a
! few instances (e. g. , days 72, 77, 80, etc.), his estimate of "heavy sleep"
coincided with the objective measure of total sleep time, but in most cases
there was no correlation.
DISCUSSION
Overview
4.
^i
Sleep Latency
The three Skylab flights differed with respect to sleep-latency characteristics.
No significant changes in this parameter were noted during the course of the 59-day
mission.	 During the 28-day mission, the inflight and postflight latencies were
significantly lower than the preflight values. 	 The 84-day flight was characterized 	 j
by "relatively long sleep latencies in the early portion of the flight, with a return
to values typical of the preflight and postflight periods in the latter half of the
mission.	 9
The alterations seen during the 28-day mission are apparently explainable,
at least in part, by a difference in the subject's routine rather than by a direct{
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environmental influence. This individual typically spent a few minutes reading
in bed prior to .falling asleep during the preflight studies in his own home.
However, he did not continue this practice either during the flight or in the
postflight period.
In only the initial portion of the 84-day mission was a degradation in sleep
latency seen. As illustrated in Fig. 43C, even in this case the magnitude of the
alterations seen was not great, and on only two nights were the values outside
the range seen during the preflight studies. In addition, it is significant that
these alterations occurred in the early portion of the study and thus cannot be
attributed to the longer duration of this mission. Consequently, it appears
reasonable to conclude that spaceflight and the associated weightless condition
do not significantly interfere with the process of falling asleep, although in
some individuals there maybe an adaptive period during which some difficulty
is experienced.
Sleep Time
The greatest overall change in total sleep time occurred during the 28-
day mission when a decrease of approximately one hour was seen inflight
compared to preflight. As indicated previously, this was a voluntary reduc-
tion in sleep time by the subject himself and thus cannot be considered as
insomnia. The subject did not complain of sleep loss and apparently was
sleeping as much as he actually required. No significant changes in sleep
times were noted during the 59- or 84-day mission. If the initial portion of
the 84-day flight is considered separately, however, it is evident that the
subject experienced some difficulty in sleeping during this time. Sleep was
also subjectively more of a problem to this individual, and he indicated on
several occasions that .his sleep was not adequate. Sleeping medication was
occasionally used by the subject, although not on the nights which were moni-
tored.
Of the three subjects, then, only the one studied during the 84-day flight
experienced real difficulty in terms of total sleep time. In this case the problem
diminished with time, although sleeping medication was used sporadically through-
out the .flight, Regarding sleep loss in terms of any possible adverse effect upon
performance capability, it seems likely only during the initial period of the 84-
day mission. This cannot be precisely assessed because of the long sample
intervals; however, even generalizing the worst case (4. 9 hours on day 4), a
severe influence upon performance would not be expected during this period.
Sleep-Stage Characteristics
Several changes in sleep-stage characteristics were common to all three
flights. Stage 3 (Fig. 50), which was significantly elevated during the inflight
portion of the 28-day mission,- also rose inflight, though not significantly,, in
the 59- and 84-day flights. Postflight, the stage 3 and stage ,4 (Fig. 51) values
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were below the preflight average in all three flights, although statistical
significance was achieved in only the 28- and 59-day missions. 	 A consistent
elevation of stage REM (Fig. 52) was seen in the late postflight period of all
l flights and was accompanied by a shortening of REM latency. 	 In the 59- and
84-day missions, a slight decrease in the average REM-period length and the
average REM-cycle length was noted inflight and postflight.
Number of Awakenings
t Although this measure was highly, variable, in general the inflight period
_ of all missions was characterized by no overall increases in number of arousals,
-..
and in the case of the 84-day mission, there weresignificantly fewer awakenings.
Significance of Results
The results obtained during the three Skylab missions suggest that pro-
longed spaceflight, with its accompanying weightless state, is not directly
associated with major adverse changes in sleep characteristics. 	 The alterations
in sleep patterns that were observed to occur were not of sufficient magnitude to
result in significant degradation of performance capability. 	 These conclusions
were somewhat unsuspected, particularly in view of the pre-Skylab reports of
sleeping difficulty that were frequently recorded during the Gemini and Apollo
flights.	 At that time, the suspicion arose that the zero-g state might, itself,
in some way disrupt the normal sleep-wakefulness mechanisms. 	 It had been
suspected that the altered sensory input to the central nervous system asso-
ciated with weightlessness might interfere with sleep onset, result in prolonga-
tion of the sleep-latency increase, and lead to long periods of wakefulness
following arousals from sleep.
	
The Skylab results, however, show that in none
of the missions was sleep latency a significant problem over the course of the
flight, and in only one case (the 84-day flight) was it even a temporary difficulty.
Furthermore, there was no evidence of consistently increased amounts of time
spent awake during the night; in fact, the number of awakenings tended to de-
crease inflight.	 The results indicate that during spaceflight of long duration
it is possible to obtain adequate amounts of sleep during regularly scheduled
eight-hour rest periods.
The most consistent and significant changes were actually observed in the
postflight period of all flights, and they pertained to sleep-stage characteristics.
Thus, stages 3 and 4 tended to be decreased in the postflight period as compared
to both pre- and inflight results
	 while stage REM was elevated in the late post-
flight period (after day R+3) and was accompanied by a shortening of REM latency.
The postflight changes in stage REM are worthy of further consideration.
-Since such findings are typical of the rebound effect seen following periods of
relative deprivation of stage REM, the question of a significant deprivation
inflight arises.	 This question is, however, somewhat difficult to accurately
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assess. When the overall averages are considered, there appears to be no
significant decrease in REM inflight. However, when the individual data
points are considered (Fig. 52), there is a suggestion that perhaps REM
percent did decline in the terminal portion of the flights. This tendency is
most prominent in the case of the 28 -day mission, in which a relatively
steady decline in stage REM percent is evident after day 17. Such a trend is
less obvious in the case of the 59-day mission, although the last two days are
below the preflight average value. In the case of the 84-day flight, the latter
portion of the mission shows only a slight indication of a decrease in stage
REM. Even though the results appear to argue against a prior period of REM
deprivation inflight as a contributing factor, it must be emphasized that re-
cordings were not made during the last two nights of each mission, and con-
sequently this situation cannot be fully assessed.
A shortening of REM latency was observed in the late postflight period
of all missions and accompanied the increase in REM percent noted during
that time. This phenomenon has also been reported as a manifestation of a
prior period of REM deprivation. Arguing against REM deprivation as a
causative agent of this change is that no lessening of the effect was evident
even on the sixth night following recovery of the 59- and 84-day missions
nor after the eighth night following the 28-day mission. Similarly, it seems
unlikely that the changes in stage REM can be attributed to alterations in the
astronauts' sleep schedules (i. e. the advances in bedtime near the termina-
tion of each mission). It has been reported that delaying sleep periods by
four hours results in a shortening of REM latency, but such findings have not
been reported with comparable advances in sleep onset. Furthermore, while
delaying sleep periods has been found to increase REM percent, advancing
sleep periods resulted in a decrease in REM percent (Taub and Berger, 1973).
The data from the postflight period of the 84-day mission further suggests
that the increase in REM percent seen late postflight is actually a delayed
phenomenon and follows a period of relative REM suppression in the immediate
recovery period. In fact, the REM percent value of 12. 1% on the first night
	
following recovery is well below any REM percent value seen either preflight
	 jI
or inflight. The value seen on day R+5 in the late postflight period is corre-
spondingly well above any value seen eitbe—, pre- or inflight. Delayed REM
rebound is not a typical finding in experiracntal situations involving REM
deprivation. It has been reported following periods of total sleep deprivation,
in which case there is an elevation of stages 3 and 4 in the first recovery night
and a later elevation of stage REM.. However, in none of the three Skylab flights
was a postflight elevation of stages 3 and 4 noted, and in fact these parameters
tended to decline. Consequently, in these cases a delayed REM rebound appearsq	 Y•	 y	 pp
to argue against prior sleep deprivation as the cause of the postflight REM changes.
In view of these findings, it seems plausible that the decreased REM latency
and increased REM percent represent a true influence of the reinstated 1-g con-
dition and that this signifies a basic alteration in the sleep-wakefulness mechanism
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of the central nervous system.
It has been postulated that sleep, and in particular the REM stage,
may be of importance in the organization and maintenance of memory
(Gaarder, 1966; see also reviews by Dewan, 1970, and Greenberg, 1970).
According to this view, REM may be involved in consolidation or reprogram-
ming of short-term memory into a more permanent or long-term form. If
this hypothesis is correct, then it might be predicted that tasks associated
with acquisition of new motor skills. and coordinated motor activity might be
associated with an increased need for stage REM sleep.
In support of this conclusion, Zimmerman et al. (1970) have .found that
during the period of adaptation to an inverted visual field, REM time was in-
creased. Following a decline to relatively normal levels after adaptation,
reinverting the visual field to normal was again accompanied by an increase
in REM-sleep amount. The situation in spaceflight may be analogous, since
the withdrawal of gravitational cues and the decrease in proprioceptive input
and altered vestibular input place a considerable burden upon the visual
system as the sole means of maintaining spatial orientation. Following the
mission, the return to Earth similarly required a period of adaptation to the
1-g condition. It might be speculated, then, that the increase in REM time
seen postflight was a manifestation of this hypothesized mechanism. There
is no evidence in the Skylab data that adaptation to zero g is accompanied by
an increase in REM time, and in fact the inflight values were either the same
or lower than preflight values. However, the hypothesis cannot be adequately
evaluated, since no sleep data was obtained prior to day 3 in any of the flights,
and thus pertinent changes could conceivably have been missed. I.f such in-
flight changes were present, however, they evidently were of shorter duration
than those seen postflight, in which case changes were seen out to day R+B.
-	 CONCLUSIONS
The objective results of these sleep monitoring experiments indicate
that man is able to obtain at least adequate sleep over a prolonged time in
space and that this can be accomplished during regularly scheduled eight-
hour sleep periods. The alterations in sleep patterns that were observed
during these missions were not of the type nor of sufficient magnitude (with
the possible exception of the initial portion of the 84-day mission) to result
in significant degradation of performance capability. The most notable changes
seen actually occurred in the postflight period, and this suggests that perhaps
the readaptation to 1 g is somewhat more disruptive to sleep than is the adapta-
tion to zero g. Yet, even in this case, the alterations seen were those of sleep 	 t ..
quality and not quantity. It is also worthy of emphasis, particularly with re-
spect to the results seen during prior spaceflights, that none of the Skylab
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crewmen complained excessively of sleeping difficulties. In fact, most re-
ported no problems with respect to sleep, and some expressed the opinion
that sleep was perhaps better in space. Viewed overall, these results are
somewhat surprising because of the frequent complaints of insomnia during
pre-Skylab missions. Apparently, the problem encountered during earlier
spaceflights was not due simply to the imposed zero-g environment. The
Skylab orbiting laboratory differed considerably from spacecraft of the
Apollo and Gemini types, although the gravitational and atmospheric factors
were the same in all cases. The working volume of the spacecraft is the
most likely influencing factor in terms ,of sleep. Skylab provided adequate
room for separate eating, exercising, working, and sleeping areas in
12 763 ft of living area. The Apollo spacecraft measured only approximately
3% of this volume, while the Gemini contained less than 1%. In these smaller
spacecraft, all daily tasks were made more difficult, and the astronauts un-
doubtedly had a greater sense of confinement. In addition, Skylab allowed the 	 ti
establishment of a daily routine which was, in most respects, directly com-
parable to ground-based, everyday activity. The subjects maintained their
Houston-based time reference throughout the flight and worked during con-
ventional hours for the most part. The individual sleeping compartments
were a definite improvement over the prior spacecraft systems, and undoubtedly
interference with sleep caused by activity of other crewmen was greatly mini-
mized or eliminated. In general, the element of risk or danger, which is
present in all spaceflights, seemed to be minimized in Skylab by the presence'
of an established daily routine, and this also may have contributed to the im-
provement in sleeping conditions.
The results also suggest areas for future study with respect to the ac-'
quisition of scientific data and in terms of man's overall adaptation to life in r
space. As indicated previously, the changes in sleep-stage characteristics 	 r '
seen postflight possibly represent a direct influence of the altered gravitational
	 fi
factors upon the sleep-wakefulness mechanisms. Future experiments, if
properly designed, could provide information of basic importance to our under-'
standing of sleep. In terms of human capabilities, we feel confident that flights
of two to three months will not be jeopardized by sleeping difficulties, but be-
yond this point we must continue to carefully evaluate sleep and ensure proper
work-rest scheduling,
32
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TABLE I
DATA FROM ALL -NIGHT SLEEK' PROFILES
28 DAY MISSION
PREFLIGHT	 AV.	 INFLIGHT	 AV	 POSTFLIGHT AV
r'
MISSION	 DAY -60 -59 -58 5 6 10 15 17 19 21 24 26 +3 1+5 +7
ANALYSIS TYPE V V V V V MA MA MA MA MA MA MA V V V
TOTAL REST TIME 7.3 7.3 8.7 78 6.6 6.3 7.7 7.4 5.6 7.7 6.5 8.0 6.0 6.86 9.3 9.0 8.5 8.9
TOTAL SLEEP TIME 6.5 6.5 7.7 6.9 6.1 5.4 5.3 7.0 5.2 6.6 6.2 7.2 5.4 6.04 9.0 8.5 8.0 8.5
TOTAL AWAKE TIME 0.74 0.81 0.96 0.84 0.31 0.85 2.43 0.45 0.47 0.81 0.25 0.67 0.26 0.72 0.26 0.45 0.44 0.36
SLEEP LATENCY 0.46 0.70 0.73 0.63
5.3
0.35 0.33 0.28 0.35 0.18 0.76 0.06 0.10 0.30 03C 0.17 024 0.16 0.19
STAGE 1% 7.4 4.3 4.2 6.8 9.5 9.8 8.3 7.7 1.1 5.4 4.4 0.6 5.95 4.0 6.5 4.8 5.1
STAGE 2% 60.3 49.6 54.5 54.8 60.2 56.4143.4 56.4 267 50.9 43.8 28.9 24.0 43.4 58.5 53.8 57.4 56.6
STAGE 3%
	 i 12.8 17.9 13.8 14.8 18.3 14.6 10.0 12.6 8.8 131 11.2 28.0 278 16.0 11.8 11.1 13.7 12.2
STAGE 4% 2.9 3.4 2.4 2.9 4.6 0.8 12.6 171 14.9 14.5 16.5 277 41.6 16.7 1.0 1.0 1.3 1.1
STAGE REM% 16.6 24.8 25.1 22.2 10.1 18.6 1 24.1 5.5 41.9 20.4 23.2 11.0 5.9 179 24.7 275 22.8 25.0
REM LATENCY 1.24 1.24 1.91 1.46 2.31 1.66 1.98 0.93* 1.18 1.11 1.07
NO. OF AWAKENINGS 19 16 24 191 10 14 12 20 20 26 22
f	 -
Fr".
t 	 ^
vj^tc06 1 p^ PACE
QUAZJ"^^ TABLE UDATA FROM ALL-NIGHT SLEEP PROFILES
59 DAY MISSION
PRE FLiGMT	 Av
	 INFLIGHT	 Av	 POSTFLIGHT AV
M SSION	 Oar -IS -14 -13 7 B 9 12 IS 19 121 24 2729 33 36 39 a2 aST 48 52 SS 56 57 ♦1 ♦3 I ^S
ANALY SIS TYPE V V V V V V V V V V V V V V y V MCA MCA
MCA M
C
A MCA
MCA MCAIMCA V V	 V
TOTAL REST TIME
	 7.7 8.4 65 75 690 6.59 8.23 7.14 732'705 6.95 727 787 8.90 7.19 738 7.21 7.23 7.55 768 682 6.78 7.32 6.61 73' 709 844 777
TO TAL SLEEP TIME 16.4 76 52 64 595 6.086.94 6.24 6.8615.75 5.47 6.50 703 6.96 646 699 616 647 614 5.04 16.48 6.44 6.3 5.77738 658
TO TAL AWAKE TIME
SLEEP LATENCY
13
0.3
0.8
0.09
13
02
1	 1
02
0.95
0.21
0.51
024
1.26
0.32
0.90
0.32
046
0.13
1.30
0.15
1.49
0.06
0.77
0.15
0.87
0.26
194
0.360.19
0.7310 38
0.12
1.07
0.14
1.08
0.37
1.54
0.12
178
0.36 010
0.64'0.17
0.16 0 . 17
1
I.0C
02
;1.32	 106
0.08'0.15 024
1
	 1 9
016
S TAGE 1% 83 7.6 106 88 75 5.9 11.2 10.6 87 11.9 11.6 9.5 113 13.5 4.3 50 75 9.4 IL 5 73 6.4 8.8 8S 104 99 102
S TAGE 2% 573 5x353.3 56.3 595 57.4 63.2 6Q4 60.7 57.8 49.2 62463.6 56660.8 591 61.0 605 594 60.9 61.0 601 59." 571 584 578
STAGE 37.	 118.0 16.4 171 174 191 13.5 13.8 17.2 18.615.8'24.6 13.9 151 200 19.1 194 115.4 17.9 16.2166 174 21.1 17! 1120	 82 101
STAGE 4% 3.1 4.9 03 28 1.8 1.9 0.8 16
10.2
1.5 1.0 3.1 1.3 0.8 1.3 1 . 1 1.4 1.3 1.3 1.3 13 1.3 1.3 14
121
^p410.4
1201	 23C
04
STAGE R EMi. 13.2 12.7 182 14 7 121 213 11.0 10.7 134 11.5 13D 9.2 8.6 14.7 15.1 11.8 13.2 10.6 85 10.1 216
REM LATENCY 16 2.2 1.8 187 1.5 1.8 2.3 26 2.2 2.1 1.6 2.2 2.3 2.9 16 1.6 2.0 2.05 0.8 1 11	 1 0.7 087
NQ OF AV AKENNGS 37 51 34 40.7 39 32 70 52 62 a3 21 51 44 25 8 25	 t 39.3 26	 31 28 5
0
TABLE III
DATA FROM ALL.-NIGHT SLEEP PROFILES
84 DAY MISSION
PRFFI 1(-,HT	 AV	 INFI IGHT	 AV	 PGSTF^jG"T	 AV
MISSION	 DAY -13 -12 -11 3 4 10 14 19 24 29 34 40 45 1 50 55 60 72 77 80 81 82 *0 ♦1 	 5 r.
ANALYSIS TYPE V V V
8 06,k
V V V V V V V V V V V V V V V V V V V V V
TO'AL REST TIME 7.43 811 1 864 6.51 6.82 6.40 7.30 728 9.78 692 813 767 1 649 865 673 6.69 8.601732 721 982 756 8.67 6.258.09 767
TOTAL SLEEP TIME 659
0.84'0.68'078
743 1 785 729
077
59C
061
488
194
600
0.39
665
065
593
1.35 1 040
937
0.66
6.26683 1 749
1.50'0.18 1 033
616
0.04024
0.26
8 3944316
031
29
039
738
1.22
5.43
1.9011.64
5.58880669
101 087
769
1
4,50;740
0.9810.78,069
65
08TOTAL 4WAKE TIME
SLEE P LATENCY 0.16 0+55 ' 010 027 0.26 0.82 0.33 0.53 0.26 018 059 020 008 014 019 009 1 0.27 Oil 10.221012 026 11 004 11 013 , 0.23 013
S T AGE	 1% 10.6 78 82 8.9 4.9 13.3 5.7 8.6 64 6.8 104 88 40 49 5.3 4.6 5.0 5.4 69 1 7.8 ,6.2 6.76 14.21 7.0 1 70 94
S TAGE 2% 59.5 541 620 58.5 573 502 584 61.4 50.8 56.1 54.3 50.9 65.5 65.0 538 616,6681 61.8 60.7 58.0'625 585 71.5171.1 '5&8 661
STAGE 3% 3.7 117 5.9 71 13.0 106 64110.3 12.2 54 12.2 13.5 46 76 9.219.51 36
0.04
1	 3.3 11.0 7.3 100 86 X 2.2 3.3 1 25 27
S TALE 4% 0.0 04 0.1 02 1.2 0.5 0.2 0.6 1.3 0.1 1.6 1.5 0.1 04 0.2 0.5 O.0 05 1 0.1 ^03 05 0.0 01	 004 00
STAGE REM°i, 26.22601238 25.3 23.6 25.4 29.3 19.2 29.4 31.6 214 25.2 257 22.1 31.6 218 245 29.5 2Q9 1 26.8 209 253 12 I 1186 346 218
REM LATENCY 0.9612 451101 147 1.24 0.12 0.79 0.95 115 1.03 1.19 2.22 1.11 1.08 1490.84 2.55
1
1.231 1.13 1.17 101 134 1.31 268'079 090 146
NO OF AWAKENINGS 20 21 21 20.7 10 8 15 15 13 20 12 16 14 6 22 6 ;	 6 1	 8 12 11 10 12 21	 11	 !24 187
`"
Day Average REM-Period Average REM -Cycle
Length (min) Length (min)
-60 17.6 92.0
-59 21.0 75.1
-58 31.5 111.0
Preflight Average 23.4 92.7
5 22. 3 134. 2
6 15.4 70.7
Inflight Average 18.8 102.5
R+3 21.5 7 3`. 7
R+5 24.0 79.3 
R+7 20.3 75.3
Postflight Average 21.9 76.-1
Day Average REM-Period Average REM-Cycle
Length (min) Length (min)
-15 25.6 158.3
-14 15.8 115.1
-13 20.6 111.4
Preflight Average 20.7 128.3
10.9 89.8
g 20.3 87.4
q 12.1 106.8
12 11.2 115.7
15 22.3 85.9
18 1E. 3 102. 2
21 10.2 69.3
24 12.8 95.2
27 21.3 185.3
29 23.8 126.4
33 14.3 79.7
36 16.6 86.2
Inflight Average 16.0 102.5
R+1 10.0 44.3
R+3` 18.0 98.0
R+5 20.7 77.0
Postflight Average 16.2 73.1
K
x
..	
_
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TABLE V
REM-Period Characteristics: 59-Day Mission
r
xi
Day Average REM-Period Average REM-Cycle
Length (min) Length (min)
-13 22.0 79.1
=12 41.0 121.9
-11 29.0 123.0
Preflight Average 31.0 108.0
3 14.8 61.0
4 12.2 58.6
10 22.7 79.3
14 13,8 64.4
19 25.4 95.5
24 26:2 79.7
29 13..9 62.7
34 19.7 72.3
40 24..3 72.0
45 28.8 97.5
55 35.0 93.8
66 32.2 118.5
72 25.8 8&4
77 33.0 106.6
80 13.8 61.1
81 22.8 85.0
82 19.2 94.0
Inflight Average 22.6 81.8
R+0 15..3 124.7
R+1 12..6 64.9
R+5 33.9 80.4
Postflight Average 20.6 90.0
1TABLE VII
Subjective Sleep Estimates by All Three Crewmen: 59 -Day Mission
i^
Mission
Day
Sleep (in hours)
SPT	 CDR	 PLT
Medications
SPT
	
CDR	 PLT
1 2 aspirin
1 seconal
1 scop/dex
1 seconal
2 7 good/fair 5 fair 7 fair 2 scop/dex 2 scop/dex 2 scop/dex
3 6 good 5 good -
2 fair
7 good 1 mylanta
2 scop/dex 3 sco /dex-P
4	 _ 7 very good 7 good 7 good 1 seconal
5 5.5 good 6 good 6 good
6' 7 good 7 good 7 good
7 5. 5 fair 6 fair 6 good
8 6 good 6 good 6 good
9, 6 fair to good 6.-5 good 7 good
10 6. 5 good 4.5 good tofaix 6 good
11 6. 5 good 6 good 6 good (? )
12 6 .fair 7 good 6.5 good
13 6.5 good 6. 5 good 6. 5 good (?
14 6. 5 good 7 good 6.5 good
15 7 good_ 7 good 7 good afrn
16 7 good 6 good 6 good afrin
17 6. 5 good 7 good 7 good
-18 6 fair 6. 5 good 6.5 good
19 6.5 good 6.5 good 6.5 good
r	 ^
^=i:*_"	 Mr..=.1^.,y 	 -^_--	 ..	 r!iti^art^-^.-yy-^w„	 ...,..._sT-	 1t -......,	 A...., ,..,__..: .r•... 	 .T„^.^s^^^,-^	 :..	 _....,	 ,. w'^,^.-.: w^	 =-'""''^'--
TABLE VII (continued)
i
j,	 Subjective Sleep Estimates by All Three Crewmen:	 59 -Day Mission
1	 Mission Sleep (in hours) Medications 
Day SPT	 CDR	 PLT SPT	 CDR	 PLT
20 6. 5 good 6. 5 good 6. 5 good
G
21 6. 5 good 1 faird2 7 good
`	 22.t 6. 5 good 6 good 6 good
23 7 good 7 good 6. 5 good
-.	 24 6.5 .fair 6. 5 good 6. 5 good
-	 25 6 good 6 good 6 good no medic tion report •g ven	 sy
w	 26a 7. 5 good 6. 5 good 6. 5 good
27 6. 5 fair 6.5 good 6. 5 good no medication report gi =en )
28 ?good 6. 5 good 6. 5 good neosporin forsty in eye
29 7. 5 fair 9 good 6.5 good
30 6. 5 good 6. 5 good 6. 5 good neosporin
31 6 good 7 good 6. 5 good
32 7 good 6 good 6. 5 good
33. 6. 5 good 6. 5 good 6. 5 good
`	 .34 6 good 7 good 6 good
35 7 good ?good 6 5 good no medication re port given
36 7 good 8 good 7 good no medication report given
37
n
7 good 7 good 6.5 good
38 6 good 7 good 6.5 good
Mission
Day
Sleep (in hours)
SPT	 CDR	 PLT
Medications
SPT	 CDR	 PLT
39 6. 5 good 7 good 6. 5 good
40 7 good 7 good 6. 5 good
41 6. 5 good 7 good 6. 5 good
42 6. 5 good 7 good 6. 5 good
43 7 good 6. 5 good 6. 5 good
44 5 good 6 good 6 good
45, 7 good 7 good 6. 5 good
46 6 good 6. 5 good 6 good
47 6 fair 6 fair 6 good
48 7 good 7 good 6. 5 good
49 7 good 8 good 6. 5 good
50; 7 good 8 good 6. 5 good no medication report gi ren
51 6. 5 good 6. 5 good 6 good
52 6 fair 6 good 5. 5 good 1 seconal
^33 7 good 7 good 7 good. 1 seconal
54 6 fair 5 good* 6. 5 good I seconal I seconal I chloralhydrate
55 5. 5 fair 6 good i6 good 1 seconal
I 
seconal 1 chloral
h,ydrate
56 6. 5 good 6 good 6 -ood 1 seconal I seconal I chloralhydrate
57 6 good 5.5 fair 5-5 .5a ood0
-F
TABLE VII (continued)
Subjective Sleep Estimates by All Three Crewmen: 59-Day Mission
Ri
{
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TABLE VII (continued)
Subjective Sleep Estimates by All Three Crewmen: 	 59-Day Mission
-	 Mission Sleep (in hours) Medications
Day SPT	 CDR	 PLT SPT CDR	 PLT
58 6 good 6 good 6 good
59 1 seconal
l -chloral
'	
60 1 scop/dex 1 seconal hydrate1 sco /dex
h
r
r
a
t
i
1 Mission
Day
Sleep Time (in hours)
Li ht or Med. Sleep	 Heavy Sleep	 Total
Medications (taken day
before sleep period shown)
1 3.0 2.0 5.0 1 scop/dexpro/el2h
2 1.0 5.0 6.o I scop/dex1 pro/eph
3 0.0 6.5 6.5 2 scop/dex
_	 1	 ro/eph
4 0.0 6.5 6.5 1 scop/dex
5 0.5 7.0 7.5
6 1.0 6.0 7.0
7 0.5 6.0 6.5
8 1.0 8.0 9.0
9 1.0 5.5 6.5
10 4.0 7.0 7-o
11 0.5 6.o 6.5
12 0.5 6.0 6.5
13 0.5 - 6.o 6.5
14 1.0 6.0 7.0
15 2.0 5._0 7.0
16 0.0 6.o 6.0
17 20 5-o 7.o
18 0.5 7.0 7.5
19 1.0 6.o 7.0
_z
}
TABLE VIII
Subjective Sleep Estimates by CDR 84-Day Mission
,"I
TABLE VIII (continued)
Subjective Sleep Estimates by CDR; 84-Day Mission
Mission
Day
Sleep Time (in hours)
Light or Med. Sleep	 Heavy Sleep	 Total
Medications (taken day
before sleep period shown)
20 1.0 6.o 7.0
21 1.5 5.0 6. 5
22 :1.5 5.5 7.0
23 1.0 6.0 7.0
24 2.0 7.0 9.0
25 1.5 6.o 7. 5
26 2.0 6.0 8.0
27 2.0 5.0 7.0
28 0.5 7.0 7.5
29 1.0 6.0 7.0
30 0.0 5.0 5.0
31 0.0 8.5 8.5
_32 0.0
_4.0 4.0
33 0.5 7.5 8.0
3 4 0.5 6.5 7.0
35 1.0 6.0 7.0
36 0.0 _6.5 6.5
37 0.5 5.0 5.5
38	 0.0	 5.0	 5.0
TABLE VIII (continued)
Subjective Sleep Estimates by CDR; 84-Day Mission
Mission
Day
Sleep Time (in hours)
Light or Med. Sleep
	 Heavy Sleep	 Total
Medications (taken day
before sleep period shown)
39 0.5 6. 5 7.0 1 chloral hydrate
40 0.0 8.5 8.5 1 suda.fed
41 1.0 6.0 7.0
42 0.5 6. 5 7.0
43 0.5 6. 5 7.0
44 0.5 6. 5 7.0
45 1.0 6.0 7.0
46 0.0 6.5 6.5
47 0.5 •8. 0 8. 5
48 0.0 4.0 4.0 1 suda.fed
49 0.5 8.0 ; 8. 5
50 2.0 5.0 7.0
51 0.15 6.5 7.0
52 0.0 7.0 7.0
53 0.0 6.o 6.0
54 0.5 6. 5 7.0 1 sudafed
55 1.0 7.0 8.0
56 1.0 5.0 6.0
57 0. 0 7.0 7.0
TABLE VIII (continued)
Subjective Sleep Estimates by CDR:
	
84-Day Mission
Mission Sleep Time (in hours) Medications (taken day
Day Light or Med. Sleep
	Heavy Slee p	 Total before slee	 eriod shown)
y
{
58 1.5 5.5 7.0
59 0•_5 6.5 _ 7.0
60 0.5 6.5 7.'0
61 1.0 6.o 7.0
6.562 1.0 5. 5
63 0.0 7.0 7.0
64 0.0 6.0 6.0 1 sudafed
65 2.0 5.0 7.0
66 1.0 6.0 7.0
67 2.0 4.0 6.-p
68 1.0 6.5 7.5
69 0.5 6.5 7.0
70 0-0 7.0 7.0
71 0.0 6.5 6.5
72 1.0 6.0 7.0
73 1.5 4.5 6.0
74 0.0 6.5 6.5
75 0.5 6.0 6.5
76 0.0 7.5 7.5 1 sudafed
LL
TABLE VIII (continued)
Subjective Sleep Estimates by CDR: 84-Day Mission
j
Mission
Day
Sleep Time (in hours)
Light or Med. Sleep	 Heavy Sleep	 Total
Medications (taken day
before sleep period shown)
77 2.0 3. 5 5.5
r
78 1.5 5.0 6.5 3 sudafed
_
79' 0.5 6.0 6. 5 2 sudafed
80 1.0 50 6.0 1 sudafed
81 0.5 6: 5 7.0
j 82 1.0 5.0 6.o )
83 0.0 6.5 6.5 1 chloral hydrate
r
^
84 5.0
a
u
j
k
j
t
TABLE IX
Subjective Sleep Estimates by PLT: 84-Day Mission
Mission
Day
Sleep Time (in hours)	 Medications (taken day
Light or Med. Sleep	 Heavy Sleep	 Total	 before sleep period shown)
1 2.0 0.0 2.0 1 scop/dex
2 2.0 5.0 7.0 1 pro/eph
3 0.0 6.5 6.5 2 pro/eph
4 0.0 6-s 6.5_ 1 pro/eph
5 2.5 4.0 6.5
6 7.0 0.0 7.0
7 0.0 6.5 6.5 1 ornade
8 1.0 8.5 9.5
9 0.0 7.0 7.0
10 0.0 6.5 6.5
1.1 1.0 5.0 6.0
12 0.0 6.0 6.0
13 0.0 6.0 6.0
14 0.0 7.0 7.0
15 1.0 6.5 7.5
16 2.0 5.0 7.0
17 15 6.0 7.5
18 1.8 6.0 7.8
19 0.5 6.0 6.5
rt
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TABLE IX (continued)
Subjective Sleep Estimates by PLT: 84-Day Mission
Mission
-
Day
Sleep Time (in hours)	 Medications (taken day
Light or Med. Sleep	 Heavy Sleep	 Total	 before sleep period shown)
20 0.0 6.5 6.5
21 0.5 6.o 6.5
22 0.5 6.5 7.0
23 0.5 6.o 6.5
24 0.5 10.0 10.5
25 0.5 7.0 7.15
26 1.0 7.0 80
27 0.0 6. 5 6.5
28 0.0 8.0 8.0
29 ' 0.5 6.0 6.5 afrin drops
30 0.5 7.0 7.5 afrin drops
31 0.5 8.5 9, 0 afrin drops
32 0.0 4.0 4.0
33 1.0 7.0 8.0 tinactin
34 0. 5, 6.5 7.0 tinactin
35 1.0 5.0 .6.0 tinactin
36 0. 5 9• A 9• `' 1 chloral hydratetinactin
37 05 6.0 6.5 tinactin
38 1.0 6.5 7.5 tinactin
r {
s
I
iE
TABLE IX (continued)
Subjective Sleep Estimates by PLT:
	
84-Day Mission
Mission Sleep Time (in hours)	 Medications (taken day
Day Light or Med. Sleep	 Heavy Sleep
	 Total	 before sleep period shown)
39 0.5 7.-0 T.5 tinactin
40 0.0 7.5 . 7.5 1 ornade
tinactin
41 0.0 7.5 7.5 tinactin
42 0.0	 _ 7.5 7.5 tinactin
43 1.0 6.0 7.0 tinactin	 ?.
Y
44 0.0 8.0 8.0 tinactin
45 0.0 7. 5 7.5
46 0.0 6.0 6.0
s
47 0.0 8. 5 8.5
48 0.0 5.0 5.0
49 3.0 2.0 5.0
	
- 1 chloral hydrate	 x
F -
50 0.0 8.0 8.0 1 seconal
51 0.0 7. 5 7.5 •
52 0.0 7.0 7.0
53 _ 0._5 6.0 6. 5
54 1.0 6.0 7.0 1 afrin
55- 1.0, 8.0 9.0
56 0:. 5	 _ '6.5 7. 0
57 1.0 6. 0 7.0
=x :tom
" ,
r	 '
nr	 TABLE IX (continued)
l
Subjective Sleep Estimates by PLT:- 84-Day Mission
Mission
Day
Sleep Time (in hours)	 Medications (taken day
Light or Med. Sleep	 Heavy Sleep	 Total	 before sleep period shown)
58 0.0 6.0 6.0
.59 2.0 3.0. 5.0 l seconal
60 0.0 8.0 8.0 2 afrin
61 0.0 7.0 7.0 afrin
62 0.0	 - 6.5 6.5 afrin
63 0.5 8.5 9.0
64 2.0 3.0 5.0 sudafed
65 0.0 7.0 7.0 sudafed2 afrin
66 0.0 6.5 6.5 afrin
67 0.0 7-o 7.0 2 afrin
68 2.0 4.0 6.o .2 afrin
69 0.0 6.5 6.5
actifed
afrin
70 1._0 6.o 7.0
71 2.5 6.o 8.5 3 actifed
72 0.0 6.0: 6.0 3 actifed
73 0. 0, 6.o 6.0 3 actifed
74 1.0 6.0 7.0 3 actifed
75 1.0 6.5 7.5 2 actifed
76 2.0 6.5 8.5 2 actifed
TABLE IX (continued)
Subjective Sleep Estimates by PLT: 84-Day Mission
E
Y
Mission
Day
Sleep Time (in hours)	 Medications (taken day
Light or Med. Sleep	 Heavy Sleep
	 Total
	 before sleep period shown)
77 1.0 6.0 7.0 actifed
78 0.0 6.0 • 6.0 actifed
79 2.0 4.0 6.0 actifed
80 0.0 5.5 5.5
81 0.0 7.0 7.0 actifed
82 0.0 7.5 7.5 1 seconal
83 0.0 6.0 6.0 1 seconal
84 X3.0 1 seconal
actifed
FTABLE X
if l ' 	Subjective Sleep Estimates by SPT:	 84 - Day Mission
,f
a'
,i
SleepTime (Hrs) Sleep Quality
Mission Light '0	 o 1 m Medications
i	 Day o r
-4a
co	 v Cr x u x b ^; >.	 `^ taken da(	 Y
qMedium Heavy c	 +-+	 .-°' before sleep
€'	 = M133 Sleep Sleep Total Remarks a ° a ^+ d ° N period shown
1 scop/dex
1 0.0 6.0 6.0 1 pro/eph
Z scop/:dex
2- 2.5 2-0 4.5 1 pro/eph
2 scop/dex
^k	 3 6.7 good X 1 pro/eph
a
4 7.0 fair X X 1 scop/dex
5 1.0 6- 5 7.5
6
1.5 6.o 7.5
7 0.0 6.5 6. 5
8 2.0 9.0 °11.0 1 Pro / eph	 z
9 1.0 6.o 7.0
10 0 .0 6.5 _ 6.5 good -	 X
11 0. 0 6.5 6.5
12 0.5 6:•o 6.5 i
x
13 0.5 6.o 6.5 s
14 - 6.9 0 5 7.4 good -_ X
<:
15 1.0 7.5 8.5 a
h
"	 16	 0.5	 6.0	 6.5
P'	 a
7
{	 n
F	 (k'
^i	 I
TABLE X (continued)
Subjective Sleep Estimates by SPT: 84-Day Misslon
Mission
Day
= M133
SleepTime (Hr s)
Remarks
Slee Quality
Medications
(taken day
before sleep
period _ shown
Light
or
Medium
Sleep
Heavy
Sleep Total
a^
'
41
r-4	 Q,
o	 ,
►4 ° d
an
4-J
U,
k
W
a^	 0on
4J
'ti	 oZ 0
b
0	 o
^ M u 1
^,
 
u >
to
;4
a0i 0 0 M
> 6
17 0.5 7 . 5 8.0 2 aspirin
18 0.3 8. 2 8.5
*19
-1.7 6. 0 7. 7 good x X
20 0.5 6.5 7.0
21 1.0 5.5 6.5
22 0.3 6.7 7.0
23 0.0 7.0 7.0
24 2.0 8.0 10.0 good
25 1.0 8.0 9.0
26	 ! 0.0 8.0 8.0
27 2.5 5.0 7.5
28 1.0 7.0 8.0
29 2.0 5. 0 7. 0 fair x x x
30 2.0 61. 0 8.0
31 1.0 7.6 8.0
32 0.18 4.0 _ 4.'8
TABLE X (continued)
Subjective Sleep Estimates by SPT; 84-Day Mission
Mission
Day
* = M133
SleepTime (Hrs)
Remarks
Sleep Quality
Medications
(taken day
before sleep
period shown
Light
or
Medium
Sleep
Heavy
Sleep Total
v
0
o o
►4	 .0,	 ct
and
a, x
W cd
I
on y,^
ro •4	 o	 ^'
^ ^ b +^
o
^	 ca	 u	 ,^
a^i ox
.^ u w
^ ^ CO
w
^	 cti	 r
33 0.4 8.3 8.7 1 pro/eph
*34 3.0 5.2 8.2 poor X X X
35 2.0 5.0 7-o
36 0.0 6.8 6. 8
37 0.0 7.8 7.8 1 dalmane
38 0.0 7.0 7.0
39 0.2 7.3 7.5
*40 0.0 8.0 8.0 good X
41 0.0 7.0 7.0
42 1.0 6.5 7.5
43 1.0 6.0 7.0
44 0.0 7.0 7.0
*45 0.0 6.5 6. 5 good X
46 1.0 5.0 6.0
47 1.5 7.0 8.5
48 1.5 3.0 4.5
TABLE X (continued)
Subjective Sleep Estimates by SPT: 84 -Day Mission
,i
Sleep Time (Hrs)_ _ Slee Quality
f	 Mission Light '^ ° ^' .°-^	 `l Medications
{	 Day or to 4 0 V x U d
o
;4 (taken day art:,
Medium Heavy o ^-' .0
.
°; m bU before sleep
Sleep Sleep Total'^= M133 Remarks ►^ o ^ ^+ M ^ a u ^ period shown
49 0.5 9.5 10.0 1 dalmane
*50 0.7 7.0 7.7 good X
u!	 51
^j 0.0 6.8
6.8
52 0.8 6.o 6.8
53 1.0 5.5 6.5
l;	 54
4^
0.0 6.7 6.7
a
*55 1.0 7.5 8.5 good X a
{	 56 1.5 4.5 6. 0
57
r
2.0 4.5 6.5
1x
i	 58 2.0 4.0 6.0 3
59 0.0 7.0	 _ 7.0 1 dalmane
t * 60 0. i0 6.7 6.7 good X 1 sudafed
61 0.0 8.0 8.0
62 3.0 3.0 6.0 1 afrin
r^.
63 0.0 10.3 10.3 1 dalmane
64 1.0 5.0 6.0
1	 TABLE X (continued)
II
Subjective Sleep Estimates by SPT; 84-Day Mission
Mission
Day
'^ = M133
SleepTime (Hrs)
Rem
-
 a rks
Sleep Quality
Medications
(taken day
before sleep
• eriod shown)
Light
or
Medium
Sleep
Heavy
Sleep Total
Q^
0
0 0 ::
a .N d
an
o,
0 d
fi
P
r, ca
v
^+	 an	 ro,
o	 0 `^
.o
^'	 '^o
a U
 a	
0
y	 x
u `^
y,
;+ 0 V wa^	
oi
65 1.0 6.0 7.0
66 1.0 5.0 6.0
67 1.0 5.0 6. 0 2 aspirin
68 1.5 6.0 7.5
69 1.0 5.5 6.5
70 2.5 4.0 6.5
71 0.5 10.0 10.5 1 dalmane
*72 1.0 6. 0 `•7. 0 good X
73 0. 5 6. 5 7.0
74 0.4 6.3 6.7 1 afrin
75 1.0 6.5 7.5
1 afrin
1 dalmane
76 1.0 8.0 9.0_
*77 1.2 7.5 8.7 good X
78 1.0 6.0 7.0
79 2.0 5.0 7.0-
80 2.0 5.0 7.0 fair X 1 afrin
Y^
d	 a
T
TABLE X (continued)
Subjective Sleep Estimates by SPT: 84-Day Mission,
3
Mis:.}ion
Day
= M133
SleepTime (Hrs)
Remarks
Sleep Quality
Medications
(taken day
 before sleep
period shown)
Light
or
Medium
Sleep
Heavy
Sleep Total
a^
o 404 °;
a ^
ago
4J
N
W d
m
on
	 r ;4.J W
o
o
v
,^
.°^4 u
w '
*81 2.2 5.0 7.2
*82 1.7 8.0 9.7 1 pro/eph
83 0.5 8.0 8.5 1 dalmane
84 ? ? ? 1 dalmane
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APPENDIX
Characteristics of the Alpha Rhythm during Prolonged
Orbital Spaceflight — Preliminary Observations
i
i
j
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INTRODUCTION
Crewmen of the three Skylab .flights experienced, to various degrees,
a complex of symptoms (a syndrome) associated primarily with the first .few
days spent in weightlessness; to a lesser extent it persisted in some degree
throughout the missions. Originally tagged 'motion sickness" by rr.edical
observers, it became apparent that this designation neither adequately nor
I!	 completely described the phenomenon.
The most basic symptom experienced by all Skylab astronauts was the
fsubjective sensation of head "fullness, " beginning shortly after orbital inser-
tion and persisting throughout the mission. In some cases, this was accom-
panied by headache of varying intensity during the first few days in orbit. Thea	
head and nasal passages seemed congested, venous distention was noted in the
head and neck, and a general puffiness of the face was noted. Some crewmen
experienced more severe symptoms, ranging from stomach awareness through
nausea to vomiting, again confined primarily to the initial days of the flight.
Medication, including mixtures of scopolamine and dextroamphetam,ine and a
mixture of promethazine and ephedrine, was utilized to counteract these latter
symptoms. Other symptoms and signs noted by more than one astronaut in-
elude paresthesias in the arms and feet, decreased muscle tone, increased
tendon reflexes, and light-.flash phenomena.
The postflight period was marked_ by an increase of symptomatology,
with vertigo or dizziness commonly precipitated by motion or standing.
Nausea sometimes was experienced, and vomiting occurred in at least one
subject.
Two major etiological .factors have been considered thus far; (1) altered
input to the vestibular system, and (2) fluid! shifts among the various body
compartments.
There is no doubt that changes did occur in the vestibular system, as
	 }
revealed by the results of the M131 Experiment. Similarly, fluid shifts'
definitely did occur, as indicated by the findings of the M092 Series. Unre-
solved is whether or not these findings relate causally to the major symptoms
and if so the recise mechanism involved
,	 p	 .
Because of the nature of a number of the symptoms (e. g. headache,
nausea, paresthesias) and observations (e. g. , vomiting, altered tendon re-
flexes), a neurological basis for this syndrome, or portions of it, should be
seriously considered. In particular, in view of the fluid-shift evidence, al-
k
	 terations of intracranial pressure, changes in cerebral hemodynamics, and
P	 metabolic factors influencing brain physiology-deserve investigation.
A2
^.	 +
i
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Although the medical experiments performed during Skylab did not in-
clude the capability for comprehensively evaluating neurological functions, the
electroencephalogram (EEG) was •recorded periodically throughout the .flights
in the performance of the M133 Sleep Monitoring Experiment. Even though the
data acquisition and analysis scheme developed for sleep monitoring was not
designed to provide EEG signals in the proper configuration for clinical diag-
nosis, it seemed worthwhile to re-evaluate the M133 data in the hope that it
might at least provide some additional clues or perhaps suggest future paths
of investigation. Consequently, a preliminary review of the Skylab 2, 3, and 4
M133 data was carried out as a pilot study, and the results thus .far are out-
lined below.
METHODS
Clinical electroencephalography is based upon interpretation of the
graphically displayed electrical signals obtained from electrodes affixed to
the scalp in precisely defined locations. Generally, a minimum of 12 record-
ing electrodes arranged in an eight-channel montage are utilized for diagnostic
purposes. Although EEG signals are known to occupy the frequency range from
do to several hundred Hz (cycles per second), clinically significant activity is
currently confined to the approximate 0.5- to 40-Hz range. Activity is conven-
tionally separated into four bands: delta activity, 0. 5-3 Hz; theta activity, 3-7
Hz; alpha activity, 8-14 Hz; and beta activity, 14-40 Hz. In a normal individual,
specific patterns consisting of mixtures of these frequency ranges are recorded
from the various locations on the scalp. Interpretation of an electroence phaio-
gram consists of evaluating and quantifying the background activity and re'7-',)gniz-
ing certain sporadic or intermittent wave .forms. Frequency and amplitude
patterns vary with age, level of consciousness, and pathological conditions,
and specific wave forms are associated with some neurological conditions.
The M133 data, while ideally suited for reliable and long-term determina-
tion of sleep status, was not adequate for a comprehensive clinical analysis
the single channel of EEG activity was derived from four electrodes (two placed
centrally and paired, and two placed occipitally and paired). In addition to the
limited spatial coverage of the head, the paired-electrode configuration pre-
vented the detection of amplitude and frequency asymmetries between cerebral
hemispheres.
The M133 protocol, designed to study the subject's sleep pattern, left the
state of consciousness and degree of alertness uncontrolled. Thus, in the pre-
sleep period when the clinical observations were attempted, the subject might
be moving, blinking his eyes, reading, relaxing, or drowsing. These factors
also degraded the quality of the clinical interpretation. In addition, in some
instances sleep onset occurred so rapidly after institution of the M133
A3
ri
Experiment that adequate waking samples were not available for evaluation.
Because of the above severe limitations, it was decided to confine the
initial analysis to one specific aspect — the frequency characteristics of the
II	 alpha rhythm.	 The alpha rhythm is the most characteristic feature of the
waking electroencephalogram in the typical individual and tends to be stable
over time with respect to frequency. 	 In addition, it is maximally expressed
in the occipital area and consequently is recorded well by the single M133
channel.
The alpha rhythm ranges from 8 to 12 Hz in normal adults and achieves
a maximal peak-to-peak amplitude of approximately 150 11V-
	 Amplitude tends
to wax and wane over time in the typical individual and under steady-state
conditions.	 This activity is usually best seen when the subject is relaxed
with eyes closed, and it typically is suppressed by eye-opening or by mental
activity with eyes closed.
In a given normal individual, the alpha frequency usually does not change
more than tO. 5 Hz from one observation to the next, even over long periods.
Various pathological conditions may disrupt the rhythm, and many drugs given
in toxic doses are known to lower its frequency.
Measurements of alpha frequency were made on each of the M133 record-
ing nights, as well as on the pre- and postflight baseline nights and on the
j.	 data obtained during the preflight laboratory baseline examination.
	 Frequency
(expressed in Hz) was determined by manually counting the number of waves
occurring over a period of time (typically ranging from I to 10 seconds) and
dividing the total by the observation time.
	 All measurements were made in
the presleep period immediately 'after the subject activated the M133 hardware
and before signs of drowsiness or sleep occurred.
	 Several samples (typically
eight) were measured in each presleep period, and the individual results were
averaged to produce a single estimate of alpha frequency for that day; the varia-
tion among the individual samples constituted the range of that single estimate.
In addition, all values were
	 when necessary	 corrected for the M133 tape-
recorder speed variation by utilizing the 10-Hz timing signal recorded on an
auxiliary channel of the system.
Although a study of the alpha-amplitude characteristics would also have
been worthwhile, the amplitude stability of the M133 recording system was not
considered to be sufficiently reliable over the course of the missions to warrent
a quantitative study.
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RESULTS
The scientist pilot (SPT) of the 84-day Skylab ,flight showed a clear-cut
and persistent elevation of his alpha frequency during the inflight and early
postflight portions of the mission as compared to his preflight studies (Fig. Al).
The overall average of the four preflight studies was 9. 6 Hz, with a range of
9. 1 to 9. 8 for the individual daily averages. Inflight, the overall average rose
to 10. 4 Hz, with a range of 9. 7 to 10. 9 Hz. The postflight period was marked
by a decline toward baseline from 10. 3 Hz on day R+0 to 9. 7 Hz on day R+5.
Only the single value for inflight day 10 (9. 7 Hz) fell within the range of aver-
ages seen preflight. When considering the range of individual samples making
up each daily average (Fig. A2), the inflight perio%i was still clearly marked by
values well outside the maximal preflight range. In .fact, no inflight individual
sample fell as low as the average for preflight day -11.
The effect showed two peaks, one in the initial period of the flight and
another near the midportion, although this aspect was difficult to evaluate due
to the occasionally long sample intervals. The alteration of alpha frequency
was evident visually when comparing samples of the recorded record obtained
from the last session preflight (Fig. A3, day -11) and the first inflight record-
ing (Fig. A4, mission day 3). Although maximal peak-to-peak amplitudes
appeared comparable in these two tracings, the alpha activity occurred more
continuously in the inflight case.
The data obtained from the SPT of the 59-day mission, while not as clear-
cut, did show several similarities to the 84-day mission. As illustrated graphi
cally in Fig. A5, most inflight daily averages for the alpha frequency were above
the overall preflight average of 9.3 Hz, and the overall inflight average of 9. 5
Hz was itself elevated. Postflight, as in the case of the 84-day mission, the
early results were elevated, while the final value attained the preflight range.
Since recording was not initiated until mission day 7, an early peak such as
that noted in the 84-day flight may have been missed.
The range of individual sample values comprising the daily averages is
illustrated in Fig. A'6, and again, though not as marked as in the 84-day mission,
the inflight values were often considerably above the maximal value noted in the
preflight period.
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The 28-day-mission results (Fig. A7) are of limited value, since only two
inflight recording samples were obtained. These values (average, 10. 2 Hz)
were both above the preflight average of 9. 9 Hz, but as indicated in Fig. A8,
they were within the range of individual values seen preflight. This flight also
differed from the other two with respect to the postflight findings. All three
measurements, obtained on days R+3, R+S, and R+7, and averaging 9. 5 Hz, 	 lu
were below the preflight value of '9. 9` Hz,
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)DISCUSSION
In all three Skylab missions, there was at least a tendency toward an
increased alpha frequency during the inflight portion as compared to preflight
studies. In two of the three flights, the early postflight period likewise was
characterized by a period of increased alpha frequency, with a return toward
baseline seen by day R+S.
The alpha rhythm, recorded from the posterior scalp areas in normal
adults, is believed to arise as a result of synaptically induced electrical activity
in the neurons of the occipital portion of the cerebral cortex. Its hypothesized
role in the cerebral integration and processing of visually obtained information
is borne out by its anatomical location in the occipital region and its reactivity
to various visual inputs (e. g. , suppression by eye-opening and by visual imagery).
Maintenance of the frequency stability of the rhythm is thought to be dependent
upon an interplay between the cortical neurons originating the electrical activity
and more-deeply lying neurons within the thalamic-projection nuclei that seem
to pace the cortical cells. Within the thalamic nuclei, relatively random input
from more-peripheral neurons is transmitted to the cortex in rhythmical bursts
gated by an interplay of excitatory and inhibitory groups of interneurons. Ul-
timately, then, the frequency of the rhythm is dependent upon biochemical or
metabolic factors at the level of the excitatory and inhibitory synaptic junctions
within the thalamic neuronal network.
As noted above, the alpha rhythm is usually quite stable over time, and
variations of more than ±0. 5 Hz are unusual. Most pathological conditions
either lower the frequency or leave it unchanged. Thus, for example, certain
drugs (e. g., Dilantin) in low doses have little influence upon the alpha rhythm;
however, with increasing or toxic doses, the alpha rhythm may slow in fre-
quency by as much as 1 -2 Hz.
Conditions causing an absolute increase in the alpha frequency are quite
rare.= It has been reported, for example, as a manifestation of nitrogen nar-
c,os'is (euphoria, impairment of mental processes, motor incoordination). in
divers exposed to elevated pressures of inspired air (Roger et al. , 1954, 1955;
Cabarrou, 1966). In these studies, it was demonstrated that the partial pressure
of nitrogen was the critical element, and elevation of the oxygen partial pressure
independently did not produce the phenomenon.
Transient increases of alpha. frequency have been. reported to occur ini
association with various alterations of mental state. Becker-Carus (1971)
reported an augmentation in alpha frequency while subjects performed tasks
of relative difficulty, whereas Martinson (1939) had earlier reported similar
observations during mental work, both easy and difficult. Other investigators
(Knott, 1938; Travis and Egan, 1938; Hadley, 1940, 1941) found comparable
frequency shifts during various other mental tasks as compared to the relaxed
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ji or resting state.	 Kamiya (1969) has reported that biofeedback techniques mayji be successfully utilized to produce changes in alpha frequency.I j^ While the possible role of such mental or psychological factors in the
Skylab situation is difficult to assess due to the uncontrolled nature of the re-
cording sessions, it is unlikely that these influences could produce the sus-
: tained and persistent alterations_ seen in the 84-day-mission results.
The Skylab findings must consequently be viewed conservatively. 	 In the
absence of the demonstration of other pathological alterations, the presence of
an increased alpha .frequency inflight and early postflight is a nonspecific find-
ing.
	
The lack of adequate controls over the experimental situation, the limited
scalp coverage available in this experiment, and the limited sample lengths
-available also argue against premature conclusions concerning the influence of
the weightless environment upon neurological function.
On the other hand, despite the numerous experimental deficiencies re-
sulting from our attempt to extract certain types of data from sources not
7 originally designed for that purpose, it does appear necessary to tentatively
conclude that some change in brain physiology did occur concomitantly with
the alpha alterations. 	 The conclusion that brain physiology was influenced
inflight in turn appears to argue for a more thorough investigation of factors
(e. g. , fluid shifts) that might conceivably elicit such alterations.
	 Thus, the
q	 ` results of this preliminary investigation of the EEG characteristics during
Skylab appear to add some evidence in favor of the hypothesis that some of
the symptoms seen during the prolonged exposure to the weightless environ-
ment of orbital spaceflight may be of neurological origin.
Future experiments utilizing EEG could be designed to further elaborate
this problem.	 An adequate montage, computer quantification of the entire EEG
spectrum, and careful clinical evaluation of properly recorded preflight, in-
flight, and postflight data should provide conclusive evidence for or against
this hypothesis.
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